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Bacterial biofilms – pathogenic matrices formed through bacterial communication 
and subsequent extracellular matrix secretion – characterize the majority of clinical 
bacterial infections.  Biofilms exhibit increased resistance to conventional antibiotics, 
necessitating development of alternative treatments.  Standard microbiological methods 
for studying biofilms often rely on in vitro systems with involved instrumentation for 
biofilm quantification, or destroy the biofilm in the process of characterization.  
Additionally, biofilm formation is sensitive to many growth parameters, and can exhibit a 
large degree of variability between repeated experiments.  This dissertation presents the 
development of systems designed to address these challenges through integration of 
 
 
continuous biofilm monitoring in a microfluidic platform, and through creation of a 
microfluidic platform for multiple assays performed on one biofilm formed in a single 
channel.  The microsystems developed in this work provide building blocks for 
developing controlled, high throughput testbeds for development and evaluation of drugs 
targeting bacterial biofilms.   
The first platform developed relied on optical density monitoring as a means for 
evaluating biofilm formation.  This method was noninvasive, as it used an external light 
source and array of photodiodes to evaluate biofilms by the amount of light transmitted 
through the microfluidic channel where they were grown.  The optical density biofilm 
measurement method and microfluidic platform were used to evaluate the dependence of 
biofilm formation on quorum sensing, an autoinducer-mediated intercellular 
communication process.  This system was also used in the first demonstration of biofilm 
inhibition and reduction by two different autoinducer-2 analogs.   
The second microfluidic system developed addressed the challenge of variability 
in biofilm formation.  Biofilms formed in a single microfluidic channel were partitioned 
by hydraulically actuated valves into three separate segments, which were then treated as 
representatives of the original biofilm in further experiments.  A novel photoresist 
passivation process was developed in order to create the multi-depth channels needed to 
accommodate both valve actuation and biofilm formation.  Biofilms grown in the device 
were uniform throughout, providing reliable experimental controls within the system.  
Biofilm partitioning was demonstrated by exposing three segments of one biofilm to 
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1.1 Background and Motivation 
Bacterial biofilms characterize a large number of clinical infections.  One estimate 
suggests that 65% of all bacterial infections involve a biofilm [1].  Biofilms impede 
phagocytosis as well as penetration of leukocytes into their structure [2, 3], reducing the 
efficacy of host immune mechanisms.  Within biofilms, high rates of mutation and 
horizontal exchange of genetic material promote selection of antibiotic tolerance 
mechanisms [2, 4] – cells associated with a biofilm are 10-1000 times more resistant to 
antimicrobial agents than free-floating bacteria [5].  Unfortunately, biofilms occur in the 
majority of clinical infections, commonly forming on catheters, prosthetic joints, 
respiratory tract surfaces, and teeth [6].   
While the detailed study of biofilms has existed for decades [7], much remains 
unknown.  In the pursuit of understanding bacterial biofilms, a number of in vitro models 
have been developed not only for understanding biofilm biology, but also for evaluating 
biofilm response to environmental challenges such as exposure to antimicrobials [8-11].  
However, just as each clinically observed infection is unique, biofilms grown in vitro also 
show variability within and between platforms [12, 13].  This variability precludes 
reliable comparison of biofilms under experimental conditions to biofilms under control 
conditions.   
Standard microbiological methods for evaluating biofilms often rely on in vitro 
systems with involved biofilm quantification instrumentation, or destroy the biofilm itself 
during characterization.  Therefore, there is a need to develop compact systems that can 
noninvasively quantify biofilm properties.  Microfluidic sensing platforms are an ideal 
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solution for addressing the need for more rigorous study of physiologically relevant 
bacterial biofilms.  Microfluidic systems provide several advantages including 
inexpensive fabrication, highly parallel throughput, and small size.  While microfluidics 
are readily compatible with noninvasive, integrated sensing technologies, biofilms 
formed in microfluidics are still most commonly evaluated using external instrumentation 
such as confocal microscopy.   
This dissertation presents the systematic development of microfluidic systems for 
biofilm applications.  It is anticipated that the microfluidic biofilm model and testing 
methodology established in this dissertation will lay the foundation for on-chip 
development of clinically effective biofilm therapies. 
1.2 Summary of Accomplishments 
As described above, a number of tools exist for biofilm evaluation, each with its 
own set of advantages and disadvantages.  This dissertation pursues the development of 
tailored microfluidics for biofilm applications.  These microfluidic systems provide 
continuous feedback and a controllable microenvironment for highly parallel studies, and 
also address biofilm variability.   
1.2.1 Development of optical density monitoring of biofilms formed in 
microfluidics 
First, a microfluidic platform and methodology were developed for forming and 
observing bacterial biofilms in microfluidics.  As indicated above, microscale flow 
systems are capable of providing a fluidic and chemical microenvironment that may be 
tailored to the application.  In this work, a microfluidic channel serving as a biofilm 
reactor was integrated with external commercial off-the-shelf optical components to 
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provide continuous optical density measurements.  While optical density had been used 
previously to monitor biofilms formed in a macroscale flow cell [14], it had never been 
used to evaluate biofilms formed in microfluidics prior to this work.   
The microfluidic biofilm reactor and sensing technique were used to continuously 
and non-invasively observe the dependence of Escherichia coli biofilm formation on 
bacterial intercellular signaling, or quorum sensing.  The effect of quorum sensing on 
biofilms was evaluated by comparing changes in optical density of biofilms formed by 
wild type E. coli, and biofilms formed by E. coli incapable of synthesizing native 
signaling molecules known as autoinducers.  Additionally, the effect of adding a set 
concentration of autoinducer to autoinducer-null biofilms was investigated.  As optical 
density is not a standard biofilm metric, results were confirmed by evaluating 
morphological properties of the biofilms using confocal microscopy.  Statistical analysis 
was applied to assess the significance and repeatability of observed optical and 
morphological differences in the biofilms formed.   
1.2.2 Use of microfluidics and optical monitoring to evaluate quorum sensing 
inhibitors 
While the developed growth and measurement system described above in 
Section 1.2.1 was used to confirm the dependence of E. coli biofilm formation on 
bacterial communication, similar studies have been performed in other formats [15-17].  
The second major accomplishment of this dissertation was the use of the microfluidic 
system for optical biofilm measurement to evaluate new autoinducer analogs that inhibit 
bacterial intercellular communication.   
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The microfluidic platform was used to show that these autoinducer analogs not 
only prevent biofilm formation by E. coli and Pseudomonas aeruginosa, but can aid in 
clearance of preexisting biofilms when applied with a traditional antibiotic.  The 
capability of continuous optical density measurement confirmed that biofilm clearance 
was continuous and was initiated upon application of the treatment.   
1.2.3 Development of a valved microfluidic system for biofilm sectioning 
The microfluidic devices used in the above studies did provide for efficient 
biofilm testing by nature of the small volumes of autoinducer or autoinducer analog 
required for microscale biofilm studies.  However, biofilm variability was still observed 
between experiments.  For the purpose of drug development, control groups must 
produce an output with minimal variability to which the experimental groups can be 
compared.  The third major accomplishment presented in this dissertation is the design, 
fabrication, and testing of a microfluidic device not only enabling concurrent studies on 
the same chip, but also allowing for multiple experiments to be performed on the same 
biofilm, eliminating variation between biofilms due to device-to-device or experiment-to-
experiment variability.   
The device created in this work uses hydraulically actuated valves incorporated in 
the microfluidic device.  In realizing microchannels with multiple depths to accommodate 
valve actuation and biofilm growth, a novel mold fabrication technique was developed 
using sequentially patterned photoresist separated and passivated by conformal coatings 
using atomic layer deposition (ALD).  The capabilities of the resulting platform were 
demonstrated through trisecting mature biofilms using the integrated valves and exposing 
the three segments to different treatments on the same platform.   
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1.3 Literature Review 
The following section presents additional background information and a review of 
literature as applicable to this dissertation.  First, a discussion of bacterial biofilms is 
presented in order to provide more detail as to their intrinsic properties, with a focus on 
factors contributing to the severity of biofilm-associated infections.  While biofilms are 
formed by many species of bacteria, emphasis is placed on E. coli and P. aeruginosa 
biofilms throughout this discussion; due to my collaborators’ experience with these 
clinically relevant species as well as the large body of research surrounding them, E. coli 
and P. aeruginosa were used throughout this research as models of biofilm formation.  
Second, alternative biofilm eradication methods that minimize the use of traditional 
antibiotics are reviewed.  Next, traditional methods for studying biofilms and their 
response to antimicrobial treatments are discussed.  The subsequent section reviews 
advantages presented by microfluidic systems and relevant microsystems technologies.  
Finally, a summary of biofilm studies performed in microfluidics is presented in order to 
emphasize the novelty of the main accomplishments presented in this dissertation.   
1.3.1 Bacterial Biofilm Characteristics 
1.3.1.1 Biofilm Formation and Growth 
Biofilm formation is initiated by attachment of planktonic bacteria to surfaces in 
their environment.  The adhesion, initially tenuous, is strengthened by genetic pathways 
promoting the secretion of an extracellular matrix, which encourages both adhesion to the 
substrate as well as cohesion between cells to form microcolonies, as shown in Figure 
1.1.  The matrix stabilizes the developing biofilm and allows for proliferation of bacteria 
within the biofilm structure, while at the same time protecting the biofilm from attack by 
6 
 
host defense mechanisms.  Cells or entire fragments of a mature biofilm often slough off, 
traveling through the host and potentially spreading the infection to a different location. 
 
Figure 1.1. Diagram of the biofilm growth cycle, from bacterial adhesion to the substrate, formation of 
microcolonies, development of a mature structure, and detachment.  Reproduced from [18].  
Bacterial adhesion is the first stage of biofilm formation, and represents the onset 
of infection.  Over the growth progression, biofilm cohesion and adhesion to the substrate 
are thought to be general indications of the maturity and strength of the biofilm.  
Interestingly, even within a species, environmental conditions can affect the degree of 
adhesion [18].  Pratt and Kolter demonstrated that E. coli K-12 grown in Lysogeny broth 
(LB) or in minimal media supplemented with casamino acids is capable of forming 
biofilms on abiotic surfaces, but is unable to initiate biofilm formation in unaltered 
minimal media [19].  In contrast, E. coli O157:H7 biofilms grown in low nutrient media 
have been shown to form more quickly and have more extracellular matrix than biofilms 
grown in media with high nutrient concentrations [20].   
A number of studies have indicated that motility is essential for biofilm initiation 
and survival [18, 21].  First, motility can aid in bringing cells to the substratum, as in the 
flagellar-mediated swimming of E. coli and P. aeruginosa necessary to convey bacteria 
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close enough to the surface to initiate adhesion events.  In E. coli, deletion or mutation of 
genes responsible for synthesis and functioning of flagella and type-I pili have yielded 
less biofilm-associated biomass as compared to wild type biofilms [15, 19].  Similarly in 
P. aeruginosa, dysfunctional flagella prevent biofilm formation [22].  Motility also 
mediates the aggregation of individual cells on the substratum into microcolonies.  
Mutation of type-IV pili and associated twitching motility in P. aeruginosa has been 
demonstrated to inhibit formation of microcolonies and structured biofilms [22].  
However in E. coli, microcolony formation is largely mediated by flagella [19].  During 
the transition from separate microcolonies to a mature biofilm, adhesion to the substrate 
and cohesion within the biofilm remain critical for maintenance and maturation of the 
biofilm, as biofilm adhesion increases with growth time and with biofilm thickness [23].   
The cohesiveness of a biofilm and its ability to retain its structure are partially 
determined by the composition of the extracellular matrix.  This matrix is heterogeneous 
in nature and typically consists of a variety of biopolymers, known collectively as 
extracellular polymeric substance (EPS).  EPS is typically composed of different types of 
polysaccharides, proteins, and DNA fragments existing in a hydrated network, 
enveloping the constituent bacteria [24].  While the exact composition of E. coli biofilms 
varies between reports, the most common major components include cellulose, β-1,6-N-
acetyl-D-glucosamine polymer (PGA), and colanic acid [25].  P. aeruginosa biofilms 
typically contain alginate, Pel (a glucose-rich polysaccharide encoded by the pel operon), 
and Psl (a mannose, glucose, and rhamnose-rich polysaccharide encoded by the psl 
operon) [26].  
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One challenge to biofilm research is the sensitive and variable nature not only of 
bacterial growth, but also of biofilm development itself [27].  Typically, wide spreads in 
biological data are narrowed by repeating an experiment multiple times, as increasing the 
sample size increases the likelihood of obtaining data representative of the population.  
Compounding the variability within one set of experiments is the variability observed 
between studies; as Beloin and Ghigo noted in a review [28], three different analyses of 
E. coli gene expression in biofilms found only two genes in common [29-31].  While 
more studies and standardization of methods between laboratories will clarify trends 
between biofilm models, it may be the case that no two biofilms can be compared.    
1.3.1.2 Transport Within Biofilms and Between their Environments 
As a biofilm grows, the thickness increases as bacteria divide and secrete more 
EPS.  The thickness and overall morphology of the biofilm are dependent on the physical 
and chemical environment.  Metabolic activity within the biofilm is dependent on the 
diffusion of nutrients, waste products, and other metabolites throughout the structure; this 
diffusion is in turn reliant on the biofilm structure and the environmental hydrodynamic 
properties, such as shear stress imposed on the biofilm.  Conversely, the biofilm itself 
interacts with the local environment, chemically altering concentration gradients and 
physically altering flow profiles; the morphological properties of the biofilm are thus 
developed through feedback between the bacteria and the environment.  A number of 
mathematical models of biofilm formation have been developed [32-34], and typically 
involve accounting for accumulation rates and transfer of cells, nutrients, oxygen, and 




Figure 1.2. Diagram representing a common mathematical biofilm model accounting for interrelated processes 
in a biofilm reactor.  Reproduced from [33].   
Changes in biomass, corresponding to the biofilm thickness, rely on metabolic 
growth rates dependent on substrate and oxygen availability; these may be modeled using 
Monod kinetics combined with species conservation in the system, summarized by 
   
  
 
    
  
       
 
where ρi is the mass concentration of species i, niz is the mass flux of species i in the z-
direction (normal to the substrate), and ri is the rate of production of i [32].   
In addition to dynamics associated with bacterial growth, division, and death, the 
fluidic environment influences the biofilm by creating convective flux of molecules into 
and away from the biofilm.  Additionally, flow over the biofilm imposes shear forces that 
can delaminate cells or segments of biofilm.  The shear stress in a flow cell is a function 
of flow rate, growth media viscosity, chamber dimensions, biofilm thickness and 
roughness, over time.  Biofilms formed under large amounts of shear stress, which may 
be created in a flow cell reactor or in vivo in arterial vasculature, are often thinner and 
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more densely packed than undisturbed biofilms [15, 32, 35].  Rochex et al. showed that 
shear stress affects the composition, diversity, and maturation rate of biofilms [36].  
Additionally, Chen et al. showed that the degree of adhesion, evaluated using 
micromanipulation, is also dependent on the shear rate at which the biofilm is formed 
[37].  Therefore, when evaluating a biofilm and its response to stimuli, the chemical and 
physical environment in which it was formed must be considered. 
1.3.1.3 Chemical Sensitivity and Antibiotic Resistance 
Bacterial biofilms exhibit elevated resistance to antibiotic treatment, compared to 
bacterial suspensions.  There are a number of hypotheses and research investigations 
concerning what mechanisms enable biofilm resistance and tolerance of antibiotics [4, 
38].  Figure 1.3 illustrates four of these mechanisms.   
 
Figure 1.3. Illustration of antibiotic resistance mechanisms in biofilms, indicating several contributors that 
individually reduce the impact of antibiotics on a biofilm.  Reproduced from [4].  
First, the EPS itself can reduce the potency of antibiotics applied to biofilms.  
Antibiotics that interact with the EPS are often prevented from completely penetrating 
thick biofilm layers [39-41].  For example, a major component of the P. aeruginosa EPS, 
alginate, is anionic, and can bind cationic antimicrobial agents and retard their diffusion 
into the biofilm [42].  However, other studies have shown that slow diffusion of 
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antibiotics through the EPS might not be a function of the EPS composition, but rather of 
other factors secreted by the constituent bacteria [43] or of the type of antibiotic and 
bacterial species [44].  For instance, while tetracycline penetrates completely into E. coli 
biofilms [45], it does not completely eliminate the biofilm, supporting multiple 
mechanisms of antibiotic resistance that encompass a range of antibiotics and growth 
conditions.  Altered chemical environments within the biofilm, for example by 
accumulation of acidic waste products [46], are also hypothesized to interfere with 
antibiotic activity [47, 48] and promote resistance.   
Second, high rates of conjugation have been observed within biofilms, and are 
largely a function of the large number of contact points between cells in a biofilm [49, 
50].  Horizontal gene transfer often promotes biofilm survival, as genes coding for 
behaviors such as antibiotic or metal resistance are often carried on plasmids that can be 
transferred between cells [51].  Interestingly, Ghigo showed that conjugative plasmids 
themselves encourage biofilm formation, and suggested that conjugative pili connections 
between cells can initiate adhesion events between cells, and thereby contribute to 
biofilm cohesion [52].   
Third, the chemical environment within biofilms is believed to promote antibiotic 
tolerance by altering bacterial rates of metabolism and growth, thereby removing 
antibiotic targets.  There is evidence of hypoxic conditions deep within biofilms, shown 
by the upregulation of genes associated with oxygen limitation.  For example, Schembri 
et al. observed increased expression in E. coli biofilms of the cydAB and b2297-hybAC 
gene clusters, shown to be induced in oxygen-limited environments [31].  As seen in 
experiments with planktonic cultures, lack of nutrients or oxygen will lower rates of 
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metabolism and growth; bacteria in biofilms have also been shown to have slower growth 
rates than bacteria in suspension [44].  Targets of antibiotics are typically processes vital 
to actively growing bacteria, such as metabolism or cell wall production.  Removal of 
these targets in slow-growing bacteria in biofilms is thought to contribute to antibiotic 
tolerance of biofilms.   
Differences in nutrient concentrations and anaerobic niches within the biofilms 
can lead to persister cells.  Persister cells are cells which have entered a dormant, inactive 
stage that are often compared to spores, and can persist even in prolonged exposure to 
elevated antibiotic concentrations.  Similar to the slow-growing cells within the biofilm, 
the antibiotic tolerance of persisters is thought to be at least partially due to the removal 
of antibiotic targets due to their dormant state.  Under favorable conditions, persisters can 
revert to live cells and reseed biofilm formation [53, 54].   
In addition to antibiotics, biofilms also exhibit resistance to treatment with 
chemical agents such as sodium dodecyl sulfate (SDS), a hydrophobic agent that serves 
as a detergent. Biofilm resistance to SDS treatment can be used as a metric to evaluate 
biofilm stability [55-57].  As an example, this technique was used by Davies et al., who 
observed that biofilms formed by P. aeruginosa with a mutation hypothesized to weaken 
the ECM were removed from the growth chamber after exposure to SDS more easily than 
wild type biofilms [56].   
1.3.1.4 Bacterial Quorum Sensing and Biofilms 
Many types of bacteria communicate with each other biochemically in a behavior 
known as quorum sensing (QS).  Quorum sensing molecules, or autoinducers, are 
synthesized and secreted into the extracellular environment.  Bacteria are capable of 
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detecting the surrounding concentration of autoinducers either by nonspecific uptake of 
the molecules or through autoinducer binding to a receptor, which both in turn will create 
a population-dependent, intracellular cascade regulating a number of genes associated 
with QS [58], as illustrated in Figure 1.4.  Numerous genes are thought to be regulated by 
QS activity; many of these genes control phenotypes associated with bacterial 
pathogenicity, including the secretion of toxins and the formation of biofilms [58, 59].   
 
Figure 1.4. Schematic of behaviors switched on by QS and accumulation of autoinducer molecules in the 
extracellular environment.  Reproduced from [59]. 
While QS systems vary between different types of bacteria, particularly between 
Gram positive and negative bacteria, the second class of autoinducer, AI-2, is referred to 
as “universal” since its synthase, LuxS, is found in more than 70 bacterial species [60].  
Strains that are believed to use AI-2 for intercellular communication include Vibrio 
harveyi, Salmonella typhimirium, and E. coli [61].  In E. coli, AI-2 is synthesized in a 
multistep process, using the enzymes Pfs and LuxS to convert S-adenosyl-L-
homocysteine (SAH) to 4,5-dihydroxy-2,3-pentanedione (DPD).  DPD is cyclized and 
undergoes further restructuring to yield AI-2, which is then secreted.  AI-2 has been 
14 
 
shown to be imported into cells both through interactions with the AI-2 transporter 
encoded by the lsrACDB operon, and also through non-specific uptake [62].  
Intracellularly, the molecule is phosphorylated by LsrK, after which it interacts with the 
repressor LsrR, allowing for transcription of the lsr operon, including genes regulating 
AI-2 uptake and processing [63]. 
QS is of particular interest as it controls a number of processes contributing to the 
formation of biofilms by a bacterial community.  Figure 1.5 illustrates several 
contributors to biofilms that have been linked to QS.   
 
Figure 1.5. Illustration of aspects of bacterial biofilm formation and growth influenced by QS.  Reproduced 
from [64]. 
P. aeruginosa uses QS extensively to modulate both biofilm formation and 
maturation, using acyl-homoserine lactone (AHL) molecules in autoinducer-1 (AI-1) 
signaling.  It has been shown that P. aeruginosa deficient in producing AHLs formed 
thinner biofilms that were more sensitive to detergents compared to wild-type biofilms 
[56].  Also, AHLs were found at higher concentrations in P. aeruginosa biofilms than in 
planktonic cultures [65].  In E. coli biofilms, addition of AI-2 was shown to increase 
biofilm mass 30-fold [15].  E. coli strains lacking the AI-2 signaling regulators lsrK and 
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lsrR have been observed to form thinner biofilms than wild type E. coli [16].  AI-2 has 
also been linked to E. coli motility [15, 25] and EPS synthesis [17], discussed in 
Section 1.3.1.1 as major contributors to biofilm formation.  While P. aeruginosa 
primarily uses the AI-1 QS system for communication and does not synthesize AI-2, gene 
expression in this species can still be regulated by extracellular AI-2 produced by 
surrounding microflora [66].  These genes include virulence genes, such as rhamnolipid 
production and exotoxin genes, implying that AI-2 is capable of altering P. aeruginosa 
gene expression and pathogenicity [66].  Interestingly, QS does not appear to have a 
significant impact on the formation of persister cells, an additional contributor to chronic 
biofilm infections.  Unpublished studies mentioned in a review by Lewis refer to 
experiments evaluating the effect of AI-2 on the incidence of persister cells [54].  These 
experiments were performed by adding spent media with high concentrations of AI-2 to a 
new culture of bacteria, which was treated with a large dose of antibiotic.  No increase or 
decrease in persister cell incidence was observed [54].   
While QS is a major contributor to infection severity, QS itself is not essential to 
bacterial growth and survival.  As a result, inhibition of QS has been pursued as an 
alternative antibacterial treatment [67-69], whereby phenomena such as biofilm 
formation and toxin secretion could be circumvented.  QS inhibition will be discussed 
later in this chapter in Section 1.3.2.4. 
1.3.2 Alternative Biofilm Treatments 
Considering both the rise of multi-drug resistant bacteria and the increased 
antibiotic tolerance of bacteria in a biofilm, the need for an alternative treatment approach 
is evident [4].  While a number of nontraditional methods for preventing or eliminating 
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bacterial biofilms are being pursued by the scientific community at large, two approaches 
currently under study by my colleagues and collaborators are presented below.  
1.3.2.1 Bioelectric Effect 
Exposure of a biofilm to an electric field applied in conjunction with antibiotics 
has been observed to enhance the normal biocidal activity of antibiotics in a phenomenon 
termed the “bioelectric effect” [70, 71].  Researchers have proposed a number of 
hypotheses for the mechanism of augmented bacterial killing by the bioelectric effect.  
The applied electric field may enhance the penetration of antibiotics into the EPS, either 
by applying electrophoretic force to antibiotic molecules or by increasing cell membrane 
permeability similar to electroporation [72, 73].  With a weakened first line of defense, 
biofilms can more readily be treated with antibiotics.  Additionally, oxidants may be 
electrochemically generated upon application of the electric field and can impede normal 
antibiotic activity [71, 72, 74].  Stoodley et al. also postulated that the biofilm may 
expand and contract depending on the polarity of an applied alternating current electric 
field, and thereby enhance convective transport of antibiotics into the biofilm [72].  
Studies of the bioelectric effect throughout literature implemented either an AC or 
a DC electric field, but never a combination of the two.  Within my research group, Kim 
et al. demonstrated the enhanced efficacy of biofilm inhibition by the bioelectric effect by 
combining alternating and direct current (AC and DC) electric fields [75, 76].  By using 
different modes of electrical energy applied, the applied voltage at which inhibition was 
observed was reduced below the limit for water electrolysis (0.82 V).  This presents a 
significant advantage, as much of the body of work on the bioelectric effect relies on 
applying voltages above this threshold, potentially generating gas within the solution.  
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While hydrolysis may contribute to bacterial biofilm killing by the bioelectric effect, the 
products can damage surrounding microflora or host cells near the biofilm and applied 
electric field.  
1.3.2.2 Quorum Sensing Inhibition 
Quorum sensing is thought to be an ideal drug target for the development of new 
antimicrobials, as it does not influence cell growth or viability, as discussed in 
Section 1.3.1.4.  Consequently, there have been many studies on QS inhibitors with the 
hypothesis that development of resistance to this treatment will either not occur or be 
delayed.  Much work has been performed developing analogs of AHL molecules [68, 69].  
The effects of these analogs on both QS and biofilm formation have been evaluated and 
verified [77, 78].  Importantly, small molecule inhibitors of AI-1-based QS were shown 
to work synergistically with antibiotics in clearing biofilms formed in vivo [79, 80].   
As AI-2 is involved in QS in over 70 species of bacteria, AI-2 signaling inhibitor 
development, as reviewed by Guo et al. [67], has the potential for widespread scientific 
and clinical utility.  There has been recent development of different AI-2 analogs shown 
to be effective QS inhibitors [81-84].  C-1 alkyl analogs of AI-2, including isobutyl-DPD, 
were developed and shown by my collaborators to be highly effective broad species QS 
inhibitors in E. coli, S. typhimurium and V. harveyi [83, 84].  Isobutyl-DPD is 
phosphorylated by LsrK in E. coli and inhibits QS-related lsr expression in the presence 
of the repressor of the circuit LsrR [84].  Additionally, Gamby et al. showed that a 
different C-1 alkyl analog, phenyl-DPD, inhibits QS-dependent production of pyocyanin 
in P. aeruginosa [85].  While AI-2 analogs able to inhibit QS in several types of bacteria 
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have been developed, prior to the work performed in this dissertation there were no 
detailed studies of how these analogs affect bacterial biofilms. 
1.3.3 Macroscale Evaluation of Biofilms 
1.3.3.1 Biofilm Reactors 
In developing biofilm science and investigating new ways to eliminate biofilms, 
researchers employ a variety of formats for growing biofilms and for evaluating their 
characteristics.  Microwell plates are one of the most common formats for growing static 
biofilms.  Microwell plate readers are staples in molecular biology and microbiology 
laboratories, and can typically measure optical absorbance, fluorescence, luminescence, 
and even scattered light.  Advanced robotic systems for filling and mixing reagents in 
microwells exist to streamline the laboratory workflow and minimize time invested by 
the researcher.   
As opposed to static biofilm reactors, growing biofilms under flow provides a 
continuous supply of nutrients to the biofilm in addition to aiding in continuous removal 
of planktonic cells, separate from the biofilm, from the system.  Flow cells can be 
purchased commercially, purchased from research groups, or can be custom-machined in 
plastic such as polystyrene. [9, 86].  They typically have one inlet, one outlet, and one 
main channel throughout which biofilms are formed.  Many of the flow cells have a 
transparent floor made from a slide or coverslip, and are designed to be mounted on a 
microscope stage for imaging during growth.  Such a configuration allows for continuous 
monitoring of biofilm physiology, or of genetic expression visible via fluorescent protein 
expression.  However, if chemical sensitivity is to be evaluated, the entire biofilm must 
19 
 
be exposed to the treatment due to the typical reactor configuration, requiring comparison 
of separately grown biofilms in order to evaluate control and experimental groups.    
The modified Robbins device is similar to standard flow cells in that a constant 
flow of growth media is provided.  However, the device contains multiple specimen 
plugs on which biofilms can be grown, as shown in Figure 1.6 [11].  After biofilm 
formation, the plugs can be removed and placed in antibiotic solutions to test for 
antibiotic susceptibility, or sonicated to remove the biofilm cells and determine the viable 
cell content.  While biofilms are grown in parallel, their analysis remains serial in this 
configuration.   
 
Figure 1.6. Schematic of Modified Robbins Device, indicating fluidic connections and plugs upon which biofilms 
grow.  Reproduced from [11].   
The Calgary Biofilm Device [8] combines the high-throughput biofilm formation 
provided by a microwell plate with the application of consistent shear stress provided by 
the modified Robbins device.  The reaction vessel has two components, illustrated in 
Figure 1.7.  Pegs on the lid can be positioned in the channels of the bottom component, 
and are sized to fit also within the wells of a 96-well plate.  The bottom of the device 
directs flow (created by placing the device on a rocking table) around the pegs so that 
biofilms growing on the pegs experience a consistent amount of shear force.  Biofilms on 
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individual pegs can be removed as in the Robbins device, and analyzed for viable cell 
content.  Alternatively, the lid can be inserted in a microwell plate filled with varying 
concentrations of antibiotics, and biofilms on individual pins tested for antibiotic 
susceptibility in parallel.  In order to image the biofilms, however, pins must be broken 
off the lid and manipulated so that the biofilms can be imaged using confocal or scanning 
electron microscopy.  After evaluating the biofilm, there is no potential for reinstating 
biofilm formation on the same pin.   
 
Figure 1.7. Cross-sectional diagram (top) and top view (bottom) of a Calgary Biofilm Device.  The diagram 
illustrates the space allowance for growth media flow between the pegs and the bottom of the device.  As seen in 
top-down view, the pegs are arrayed in a 12x8 array compatible with a 96-well plate. Reproduced from [8].   
1.3.3.2 End-point Measurement Methods 
One of the most commonly used techniques for biofilm quantification is crystal 
violet staining [87-89].  Crystal violet is applied to a biofilm, where it binds to negatively 
charged exopolysaccharides and molecules on bacterial cell surfaces.  After rinsing 
excess dye from the biofilm, the bound stain is solubilized and is then quantified via the 
optical absorbance of crystal violet at 590 nm.  While this staining method is a standard 
biofilm metric, it can produce variable results as the stain penetration into the biofilm or 
degree of binding to the cell wall can be variable.  This can be addressed by removing the 
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biofilm from the reactor surface and thoroughly mixing it with the stain, sacrificing 
morphological information at the same time.   
As high resolution microscopic methods become more widely available, biofilms 
are commonly evaluated using confocal microscopy and scanning electron microscopy 
(SEM) [32, 90-93].  Confocal microscopy provides insight into the structures formed by 
fluorescent cells.  Fluorescence can be obtained by using a cell line modified to express a 
fluorescent protein either constitutively or upon the application of a stimulus.  However, 
the insertion of such plasmids can affect other aspects of the bacterial phenotype, 
potentially creating a biofilm that does not reflect what might be formed by the wild type 
strain of bacteria.  For example, three different strains of E. coli engineered for 
constitutive expression of green fluorescent protein (GFP) all exhibited decreased 
sensitivity to β-lactam antibiotics, but showed increased sensitivity to other antibiotics 
including tetracycline, ciprofloxacin, and vancomycin [94].  Alternatively, the biofilm 
can be fluorescently stained using a number of stains, often available in commercial kits 
such as the Filmtracer™ LIVE/DEAD® Biofilm Viability Kit (Invitrogen Corp.).  
Provided a fluorescently stained biofilm, confocal microscopy will generate images at 
different heights throughout the biofilm.  The series of images can be used to generate 
three dimensional representations of biofilm structures using software such as Imaris 
(Bitplane, Inc.) or Volocity (PerkinElmer, Inc.).  Quantitative information can be 
obtained through image analysis, often performed using COMSTAT, the software 
developed by Heydorn et al. to aid in standardization of biofilm quantification techniques 
[12, 95].  This software provides morphological data, such as average thickness, 
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substratum coverage, biomass, and roughness, all of which can be used to characterize 
biofilms.   
SEM provides more detailed information than confocal microscopy by virtue of 
its high resolution.  This technique can be used to evaluate the quality of the extracellular 
matrix and its interaction with cells within the biofilm [92, 93, 96].  Traditional SEM 
techniques involve supercritical drying and coating of the biofilm with metal for electron 
microscopy in a high vacuum environment, dehydrating the biofilm in the process and 
preventing further growth.  ESEM allows imaging of the biofilm in a hydrated state, 
providing information more representative of the biofilm in its natural state.  Electron 
microscopy is typically implemented as an endpoint measurement technique.  Factors 
contributing to the inability to use ESEM throughout growth include the performance of 
imaging at low temperatures close to freezing and the need to have the surface of the 
biofilm interact with the electron beam, preventing imaging through an enclosed biofilm 
reactor.  A comparison of images obtained using confocal microscopy, SEM, and 




Figure 1.8. Images of a Bacillus subtilis biofilm obtained using A) Confocal microscopy C) Field emission SEM, 
similar to standard SEM apart from the use of a field emitter instead of a thermionic emitter in order to 
minimize distortion and obtain higher resolution B) ESEM performed at a chamber pressure of 4 Torr D) 
ESEM performed at 5 Torr.  Reproduced from [96].   
Biofilms may also be analyzed for chemical content using destructive processes to 
prepare samples for quantification of total protein content, total organic carbon content, 
and microarray analysis [14, 15, 90].  While these techniques provide multiple types of 
information about biofilms, they are all end point measurements, as the biofilm is 
destroyed in the analysis process.  Therefore, in order to obtain information 
corresponding to biofilms at different points in growth, several experiments must be 
performed.   
1.3.3.3 Noninvasive Measurement Methods 
As evident in the biofilm reactors presented above, one challenge in studying 
biofilms is observing biofilm properties in a non-destructive manner.  While not as 
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commonly used as the endpoint techniques described above, a number of methods which 
can be used on unlabeled biofilms at any point during growth have been developed; a 
review of such techniques has been presented by Janknecht and Melo [97].  One such 
method to evaluate biofilms is via their electrical properties, as the cells and EPS within 
biofilms serve as a dielectric material and thereby provide the biofilm an electrical 
impedance that can vary with time or with structure and composition of the biofilm.  The 
electrical signature of a biofilm can be assessed using methods such as electrochemical 
impedance spectroscopy or capacitive measurement techniques [97-100].   
Fiber optic sensors have also been used to evaluate biofilm growth noninvasively 
[97].  The amount of biofilm may be quantified by the observed turbidity in the biofilm 
reactor; this can be implemented as a differential measurement, with one turbidity 
measurement obtained at the biofilm, and one measurement at a point with no biofilm 
due to water jets physically removing biofilm from that location [101].  Alternatively, 
Tamachkiarow and Flemming evaluated the biofilm formed at one location in a brewery 
water pipeline by using a fiber optic probe to measure light scattered from a separate 
source, and monitoring the change over time [102].   
Using a similar principle as the fiber optic device of Tamachkiarow and 
Flemming, Bakke et al. performed a detailed study investigating biofilm optical density 
as a unique property by which biofilms may be characterized.  P. aeruginosa biofilms 
were formed in macroscale flow cells in the configuration shown in Figure 1.9.  Growth 
media was introduced into two parallel rectangular tubes to simultaneously grow biofilms 
over the surfaces of both tubes.  The optical density at 420 nm at selected points in time 
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was measured between points A and D as shown in Figure 1.9 using a fiber optic probe 
[14].   
 
Figure 1.9. Schematic of biofilm flow cell reactor used by Bakke et al.  Biofilms were formed in parallel 
rectangular tubes (1.0x3.0x300 mm), formed by inserting a water-filled capillary into a larger square tube in 
order to create a large surface area for biofilm formation. Optical density at 420 nm was measured between 
points A and D using a fiber optic probe.  Reproduced from [14]. 
The change in biofilm optical density from the baseline was compared to the 
change in optical thickness; while the two were not directly correlated, it was shown that 
as the biofilm grows, optical density increases.  The optical changes observed were 
hypothesized to be due to light scattered by cells within the biofilm, similar to turbidity 
measurements performed on bacterial suspensions in a spectrophotometer.  While the 
implementation of the flow cell precludes continuous optical measurements, this work 
demonstrated the viability of biofilm monitoring via optical absorbance.  The principle of 
detection may be applied to microscale systems integrated with inexpensive optical 
components (i.e. a light source and a photodetector) capable of continuous optical 
sensing.   
1.3.4 Microfluidics 
Microscale systems are able to address many of the disadvantages to the 
previously described macroscale biofilm models and measurement techniques.  The use 
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of microfluidics in particular allows for greater control of the fluidic environment and 
incorporation of microfabricated sensors or micropatterned growth substrates [103, 104].  
Additionally, larger platforms such as microwell plates require large sample sizes, often 
on the order of tens of microliters, while microfluidic systems may use reagent volumes 
on the order of nanoliters.  While large samples of bacteria are simple to obtain, as they 
are a self-renewing resource, it is often difficult or expensive to obtain large volumes of 
reagents such as antibodies or drugs under development.  Several microfluidic methods 
have been employed in biological applications such as electrophoresis, on chip PCR, and 
cell-free protein synthesis [105, 106].   
While the simplest microfluidic systems, single channels or chambers, are 
miniatures of existing macroscale platforms such as microwell plates or flow cells, 
complex fluid handling architectures can be integrated with arrays of channels or 
chambers in the epitome of a “lab on a chip”.  On-chip pumps can provide tunable flow 
of solutions throughout a device without the need for an external pump.  Integrated 
valves can direct this flow to designated locations on demand.  There are many 
configurations of valves, such as implementation of external pins or solenoids [107, 108] 
to compress a fluidic channel embedded in the flexible silicone polydimethylsiloxane 
(PDMS).  Integrating valves into PDMS itself and using a pressurized gas [108-111] to 
control the valve orientation is a popular valving scheme used in much of today’s 
microfluidic work.  These types of integrated valves are convenient for imaging the 
contents of the microfluidic channels, since using only an in-plane gas line to actuate the 
valves maintains an open line of sight for optimal characterization of channel contents via 
microscopy.   
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A unique feature of microfluidics is their ability to be integrated with sensors by 
virtue of compatible fabrication technologies.  A multitude of microfabricated sensing 
systems have been developed for biological applications using a variety of transduction 
mechanisms.  For example, impedimetric and capacitive sensors can measure changes in 
electrical properties imposed by deposition of molecules or cells on the surface of a 
microfabricated sensor [100].  Surface acoustic wave (SAW) sensors use a piezoelectric 
material to generate surface acoustic waves whose resonance properties change with 
mass deposition on the sensor [112, 113].  Cantilevers with surface functionalization 
layers will display altered mechanical properties, such as bending or resonance change, 
upon analyte binding to the surface.  The change in mechanical properties can be 
measured a variety of ways, such as with integrated piezoresistors [114] or with external 
interferometric readout [115].  These sensors, by nature of being batch microfabricated, 
offer the benefits of being small, inexpensive, and easily integrated with many other 
types of sensors to create a multimodal sensing platform.  Microscale sensing provides 
the added benefit of being as sensitive as macroscale methods, while maintaining fast 
response times.   
1.3.5 Microsystems for Biofilm Growth and Characterization 
While studies of biofilms and of microfluidics have existed for decades, recently 
the two fields have merged and spawned research providing new insight on the 
mechanical properties of biofilms [116, 117], roles of intercellular communication [32, 
111, 118-120], and development of antibiotic resistance [121] among other topics [122, 
123].  Highlights of published work from this body of research are summarized below in 
Table 1.1.   
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The majority of these studies utilized direct measurement of biofilm thickness and 
morphology using microscopy and image analysis, but did not demonstrate real-time 
monitoring of bacterial biofilm characteristics.  One study, by Richter et al., employed a 
microfluidic platform with integrated electrodes for impedance spectroscopy to evaluate 
fungal biofilm formation [104].  However, this method has not expanded to the 
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community of bacterial biofilm researchers.  Some of the studies leveraged properties of 
microfluidics to create environments more difficult to obtain with traditional reactors.  
Diffusive mixers have been incorporated within microfluidic platforms for biofilm 
formation so that two solutions, such as growth media and an antibiotic, may be injected 
and mixed to either one [121] or several desired concentrations [111, 120].  Kim et al. 
used controllable PDMS structures to isolate, then integrate cultures of epithelial cells 
and bacteria [124].  The same group also used integrated PDMS valves to control seeding 
of a device with bacteria introduced from a port separate from the port for growth media 
introduction [111, 120, 124]. 
Once the biofilm has formed in a microfluidic device, variability between devices 
still exists, as with macroscale biofilms [12, 125].  As a result, many studies performed 
on biofilm formation are conducted as demonstrations and rarely report more than three 
repetitions of an experiment.  One method of addressing device-to-device variation is 
performing multiple experiments simultaneously on parallel biofilms grown in separate 
channels of the same device [111, 120].  Although some work has investigated the 
reproducibility of biofilm morphology in flow conditions [12] and the correlation 
between biofilm optical density and carbon content [14], these investigations have been 
performed on biofilms formed in macroscale reactors.  While there is no variability 
difference between micro- and macroscale reactors at the cellular and molecular level of 
biofilm formation, microscale confinement alters the surrounding fluid dynamics and 
yields biofilms with compositions, morphologies, and variabilities that cannot be 
compared to those of biofilms in macroscale reactors.  There have been no reported 
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investigations of either morphology or optical density reproducibility in microfluidic 
biofilm reactors prior to the work performed in this dissertation. 
1.4 Structure of Dissertation 
The preceding chapter presented the motivation behind the work performed in this 
dissertation, along with background information to establish the context of the research 
work.  The following three chapters each address one of the three major accomplishments 
presented in Section 1.2.  Chapter 2 presents the development of a microfluidic platform 
featuring continuous optical measurement of biofilm growth, and a discussion of biofilm 
reproducibility and data analysis.  Chapter 3 covers the application of this platform 
toward evaluating inhibitory effects on biofilms by a new class of quorum sensing 
inhibitors.  Chapter 4 presents the design, fabrication, and experimental demonstration of 
a microfluidic device designed not only to multiplex biofilm experiments, but also to 
address variation between biofilm experiments.  Chapter 5 summarizes the work of the 
dissertation, and concludes with a discussion of future studies that can be performed as 




2 Monitoring of Biofilm Formation in Microfluidics via 
Optical Density  
This chapter covers the use of optical density monitoring as a means of evaluating 
bacterial biofilms formed in microfluidics.  The development of the first microfluidic 
platform with optical density biofilm monitoring is described, including the device 
fabrication, biofilm growth, and data analysis.  Also included is a brief description of 
activities that have emerged from this preliminary development, namely work performed 
by Mr. Matthew Mosteller.  The development of the first-generation device has also been 
published in the Journal of Micromechanics and Microengineering [118], and the second-
generation device development has been reported in the Master’s thesis of Matthew 
Mosteller [126].   
2.1 First Generation Device 
The biofilm optical measurement platform presented below is the first 
demonstration of measuring optical density of biofilms formed in a microfluidic 
environment.  Biofilm optical density was continuously and non-invasively measured 
with a simplified experimental setup using off-the-shelf electrical components.  Biofilm 
optical properties were corroborated with biofilm morphological properties quantified 
using confocal microscopy and image analysis.  The platform was used to investigate the 
dependence of Escherichia coli biofilm formation on quorum sensing.  This investigation 
was achieved by comparing optical and morphological data between wild-type E. coli 
and E. coli incapable of quorum sensing molecule synthesis.  The repeatability of 
biofilms formed in the platform using the developed methodology was also evaluated, 
toward the end of using the system as a reliable drug evaluation platform.  
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2.1.1 Platform Overview 
As discussed in Section 1.3.4, microfluidics provide a number of advantages for 
biofilm research.  Batch fabrication and the ease of operating simultaneous experiments 
allow for high throughput studies.  The small volume serves as a tightly controllable 
microenvironment, and minimizes the amounts of reagents required for assays.   
While a number of measurement techniques are available for integration within 
microfluidics, optical density was used for biofilm evaluation in this work.  Optical 
density monitoring requires no labeling of bacteria with DNA-binding fluorophores or 
constitutive expression of GFP, preserving the viability and phenotype of the biofilm.  
Additionally, it can be performed in a continuous manner so that the real-time response 
of biofilms to stimuli can be observed.  Bakke et al. showed that as a biofilm grows, its 
optical density increases due to the increased amount of light scattered by the biofilm 
structure and constituent bacteria [14].  The change in optical density from the baseline 
biofilm condition (ΔOD) over time can be defined as  
ΔOD(t) = -log10(I(t)/I0), (1.1) 
where I(t) is the transmitted light intensity measured by the photodiode at a selected time 
t, and I0 is the baseline intensity measured after inoculation of the channel at the 
beginning of biofilm growth.   
The microfluidic platform for optical density measurement of biofilms consisted 
of a micropatterned base providing measurement windows, a molded PDMS microfluidic 
channel, photodiodes placed under measurement windows, and light emitting diodes 
(LEDs) providing incident light.  A cross-sectional schematic of the device indicating the 




Figure 2.1. Schematic of PDMS microfluidic channel integrated with optical source and detector for optical 
density measurement of biofilms within the channel.  The LED provided incoherent light, which scatters off the 
surface of and within the biofilm.  Light that is transmitted through the pinhole in the chrome represents a 
combination of light that does not interact with the biofilm and light scattered from the biofilm.  Overall, less 
light sensed by the photodiode implies a greater amount of biofilm either impeding transmission or scattering 
light away from the pinhole.  Note: not to scale.  
As illustrated in Figure 2.1, LEDs flooded the device with incoherent light, illuminating 
the biofilm directly above patterned pinholes in the chrome as well as adjacent biofilm.  
Here, the incident red light was assumed to interact with the biofilm solely through 
scattering and reflection; since characteristic absorbance peaks have not been reported for 
biofilms, it was assumed that optical density at any visible wavelength would provide 
representative information on the biofilm state.  As DNA and proteins containing 
aromatic amino acids absorb light in the ultraviolet range at 260 and 280 nm respectively, 
the use of red LEDs with a peak emission wavelength of 660 nm was expected to 
minimize specific optical absorbance interactions with protein and DNA [127].   
The use of LED illumination has its own set of advantages and disadvantages.  
Incoherent light yields a low signal since much of the light generated by the LED source 
does not interact with the biofilm.  The biofilm itself acts as an additional source of 
scattering due to its heterogeneous composition of cells, EPS, and water.  While the 
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photodiode may detect light scattered from an area of biofilm not directly above the 
measurement window, sections of biofilm above the window may also not be completely 
represented due to scattering of light away from the photodiode.  The pinhole patterned in 
the chrome eliminates the majority of stray light from the LED, as well as some of the 
scattered light from the biofilm.   
2.1.2 Platform Fabrication, Assembly, and Interfacing 
2.1.2.1 Fabrication 
As mentioned above, the microfluidic channel itself was formed by molded 
PDMS placed on top of a transparent base serving as the channel floor.  The base was 
fabricated on a coverslip, providing a substrate that is both transparent and thin enough 
for high resolution inverted confocal microscopy of the biofilm.  A 200 nm layer of 
chrome was sputtered onto the coverslip and patterned into two 200 µm x 200 µm 
windows using contact photolithography and chrome etching (see Appendix A, Mask 
#1).  The windows were positioned 5 mm apart, with the first window 7.5 mm from the 
inlet.  The chrome served as an opaque barrier to light, while the two patterned areas in 
each channel served as observation windows through which the optical density of the 
biofilm was measured.   
The microfluidic channel was constructed of molded polydimethylsiloxane 
(PDMS).  The mold was fabricated by patterning 100 µm-thick Microchem SU8-50 on 
silicon, using contact photolithography (Appendix A, Mask #2).  PDMS (Dow Corning, 
Sylgard 184) was prepared in a 10:1 ratio of base to curing agent, poured onto the mold, 
and cured at 80 ºC for 20 minutes.  The microfluidic channel was 500 µm wide, 100 µm 
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in height, and 2 cm long.  Ports for interfacing the microfluidic channel to Tygon tubing 
were punched into the PDMS using a 2 mm dermatological punch.   
The PDMS was reversibly bonded to the un-patterned side of the coverslip by 
soaking the side of the PDMS to be bonded in methanol for 1 minute, then aligning and 
placing the PDMS onto the chip.  This bonding technique was found to be most effective 
when the PDMS was placed on the un-patterned side of the coverslip, as opposed to the 
chrome-coated side.  Reversible bonding allowed for disassembly, cleaning, and reuse of 
the chip after it has been used for a biofilm formation experiment.  In the development of 
this measurement platform and technique, reusability was a critical factor as many 
experiments were performed in order to characterize the system.  While fabrication of the 
patterned coverslip and PDMS microfluidic channel were not prohibitively difficult, 
researcher time and resources were conserved by avoiding fabricating additional 
platforms through reuse.   
2.1.2.2 Fluidic Interfaces 
Following assembly, the platform was affixed to a glass slide for more robust 
handling, and the slide was aligned so that the observation windows in the coverslip were 
positioned over two external photodiodes sensitive to visible light.  One end of the 
0.38 mm ID Tygon tubing (Cole Parmer #EW-95609-14) was connected to a 
1/16” barbed tubing connector (Cole Parmer #EW-06365-15) via a short section of 
1/16” ID tubing (McMaster-Carr #5894K11) that snugly fit both the narrow tubing and 
the barbed tubing connector.  Epoxy was applied to all joints to guarantee leak-free 
connections for maintenance of continuous and stable flow of growth media throughout a 
biofilm formation experiment.  Connectors were inserted into the ports in the PDMS 
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layer, so that one tube was connected to a syringe pump and one tube was inserted in a 
reservoir to provide flow of growth media, bacteria, or fluorescent stain.  Epoxy was 
again applied at the connector-PDMS interface to ensure a leak-free connection.  The 
entire assembly was placed inside an incubator at 37 °C.  A schematic of the arrayed 
microfluidic chips is shown in Figure 2.2, and photographs of an individual chip and 
platform setup are shown in Figure 2.3.  
 
Figure 2.2. Schematic of microfluidic flow cell in which biofilms were formed.  The width, length, and depth of 
the straight microfluidic channel used in these studies were 500 µm, 2 cm, and 100 µm, respectively,  A syringe 
pump operating in withdrawal mode provided flow throughout the channel of suspended bacteria, growth 
media, or fluorescent dye from a reservoir.   
 
Figure 2.3. a) Photograph of assembled microfluidic device with fluidic connections b) Photograph of 




2.1.2.3 Optical Components 
Optical density measurement of light transmitted through the microfluidic channel 
and its contents required a light source and a photodector.  In this work, an array of high 
intensity red LEDs (Lumex SSL-LX5093SRC/E), the source of visible light for optical 
density measurement, was aligned to an array of microfluidic platforms as shown in 
Figure 2.3b.  The LEDs were connected to a 5 V voltage regulator and a dedicated power 
supply (Appendix B).   
Two off-the-shelf photodiodes (Sharp BS520E0F) for measuring light transmitted 
through the microfluidic channel were placed under each microfluidic platform, with one 
photodiode centered under each window.  As photodiodes transduce the intensity of 
incident light into a current, a transimpedance amplifier was used to translate the current 
output of each photodiode into a voltage (Appendix B).  Differential voltages for each 
photodiode were then fed to a data acquisition (DAQ) card (National Instruments USB-
6221) with LabVIEW control of inputs and outputs.  Proper alignment was verified by 
monitoring the photodiode output during alignment.   
2.1.2.4 Multiplexed Photodiode Output Measurements 
In order to obtain sufficient data for statistical analysis to confirm observed trends 
in biofilm growth, it was necessary to perform a large number of experiments.  A custom 
electrical logic circuit was developed to streamline simultaneous testing of up to nine 
devices.  Evaluation of one photodiode output required differential measurement of two 
analog voltage inputs by the DAQ; as each device had two photodiode measurement 
windows, 18 analog inputs were required in order to measure nine devices.  As the USB-
6221 had only 16 analog inputs, a separate multiplexing circuit was constructed.  As 
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shown below in Figure 2.4, an off-the-shelf, 4-channel differential multiplexer (Fairchild 
Semiconductor MM74HC4052) was used to reduce four photodiode outputs to one 
(Appendix B).  A digital counter was created in LabVIEW and applied to the multiplexer 
via the digital output pins of the DAQ.  The LabVIEW program was configured to record 
a time stamp, the state of the counter, and the photodiode outputs averaged over 5 
seconds.  The LabVIEW files created were processed by a MATLAB program (Appendix 
C) so that the multiplexed signal could be divided between the measured photodiodes 
according to the counter state.   
 
Figure 2.4. Schematic of multiplexer integration with photodiode measurement.  A digital counter generated by 
LabVIEW controls the multiplexer state, and determines which photodiode signal is reflected in the multiplexer 
output.  Both the multiplexer output and the state of the counter over time are exported to MATLAB, where the 
photodiode outputs are separated. 
Key considerations with the system, especially when performing many parallel 
measurements, are electrical noise and interference.  A common phenomenon observed 
with multiple analog inputs on a multiplexed-sampling DAQ card is “ghosting”, where 
changes in one input are observed in the adjacent input due to accumulation and transfer 
of charge between channels.  Measures were taken to prevent ghosting as well as 
interference between photodiode outputs at the hardware level.  “Dummy” channels were 
used between measurement channels on the DAQ card, so that two photodiode inputs 
were never read one after the other.  Implementing the differential multiplexer also 
created more channels free for use as dummy channels.   
39 
 
2.1.3 Experimental Methods 
2.1.3.1 Strains Used 
E. coli W3110 served as the standard for biofilm formation.  To probe the role of 
quorum sensing in optically detectable biofilm formation in microfluidics, a quorum 
sensing-null W3110 mutant, MDAI2 [128], was used.  MDAI2 does not express LuxS, an 
enzyme responsible for the synthesis of AI-2, the primary signaling molecule used by 
E. coli.  Restoration of quorum sensing capabilities was evaluated by adding 30 µM AI-2 
to MDAI2 cultures; growth media was refreshed every 12 hours to ensure viability of the 
AI-2 molecules.  Bacterial cultures were grown overnight, then diluted to the desired 
OD600.  All cultures were grown in Luria Bertani (LB) growth media. 
2.1.3.2 Validation of Optical Response of the System 
The photodiode sensitivity was characterized by filling the microfluidic channel 
with bacterial suspensions of a known OD600 measured with a standard spectrophotometer 
(Beckman Coulter, Inc.).  E. coli W3110 suspensions were grown as described in 
Section 2.2.2.1, and prepared in dilutions with OD600 values of approximately 0.1, 0.25, 
0.5, 1.0, 2,0, 3.0, and 6.  The microfluidic channel was disinfected with a flow of 70% 
ethyl alcohol.  An optical density for each suspension was obtained using the developed 
platform by first introducing sterile LB media into the channel as a blank and measuring 
the photodiode response over 5 minutes (without flow in the channel).  After rinsing the 
channel with deionized (DI) water, the suspension was injected into the channel.  The 
photodiode response was measured over 5 minutes, followed by rinsing the channel with 
DI water in preparation for the next sample.  Optical density values obtained with the 
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microfluidic platform were calculated using the average responses over the 5 minute 
measurement time period, and averaged between photodiodes.   
2.1.3.3 Biofilm Growth 
Prior to channel inoculation with bacteria for biofilm growth, the channel was 
disinfected with a flow of 70% ethyl alcohol. The bacterial suspension, diluted to an 
OD600 of 0.25, was suctioned into the assembled microfluidic platform.  The inoculum 
was incubated in the channel for 2 hours to allow bacterial adhesion to the substrate.  The 
channel was rinsed with LB growth media for 15 minutes at a flow rate of 10 µL/hr, 
corresponding to an average velocity of 0.06 mm/s, to remove non-adherent cells.  The 
platform was continuously operated at 10 µL/hr over the biofilm growth period. 
The initial optical density of the biofilm was measured after rinsing, using the 
average of the two photodiode outputs over a period of 15 minutes.  The photodiode 
outputs were then continuously monitored using the DAQ card and recorded using NI 
LabVIEW.  Although there were two photodiodes and two measurement windows for 
each microfluidic channel, the outputs of the photodiodes were typically within 10% of 
each other; therefore, the average of the two photodiode outputs in each channel was used 
in all optical density calculations. 
2.1.3.4 Confocal Microscopy and Image Analysis 
While optical density is one characteristic of a biofilm, many biofilm studies 
evaluate morphological characteristics of the structure formed using microscopy, as 
discussed in Section 1.3.3.2.  In this work, confocal microscopy was used to obtain 
morphological data that could be compared to optical density data.  At timepoints 
selected for microscopy, flow of growth media over the biofilm was ceased.  The channel 
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was rinsed with DI water then treated with a Live/Dead Bacterial Labeling Kit 
(Invitrogen # L7012).  The dye was fixed by flowing 3% paraformaldehyde into the 
channel.  Labeled samples were imaged using a confocal microscope (Zeiss LSM 710).  
Z-stacks were analyzed using COMSTAT to obtain morphological properties of the 
biofilm [8].  
2.1.3.5 Calculation of Optical Density Changes 
The change in optical density from the baseline biofilm condition was calculated 
using Equation 1.  As mentioned above, the transmitted intensity I(t) was continuously 
measured by the photodiodes, and the baseline intensity (I0) was obtained by averaging 
photodiode outputs over the 15 minute period after rinsing non-adherent bacteria.  As the 
type of photodiode used has its own conversion function between output current and 
incident illuminance, the transfer function was estimated from the data sheet and is 
reflected in Appendix C.  The photodiode output currents were derived from the voltage 
using the resistor values used in the transimpedance amplifiers, also reflected in the 
calculations in Appendix C.   
2.1.3.6 Data Analysis 
Morphological and optical data were both reported as the average of values 
obtained at each of the two windows in a microfluidic channel.  In some experiments, as 
detailed below, net changes in optical density and thickness were compared between 
groups at selected time points to evaluate significant differences.  Since changes in 
optical density were continuously measured, 30 minute averages centered around the time 
point of interest were used as data points for comparison.  Changes from the baseline 
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optical density and average thickness values were compared using Student’s t-test.  
JMP® statistical analysis software was used for all statistical calculations. 
2.1.4 Results and Discussion 
2.1.4.1 System Characterization 
The optical response of the system was characterized using bacterial suspensions 
with OD600 values obtained with a standard spectrophotometer.  A graph of the data and a 
linear fit thereof are presented below in Figure 2.5.   
 
Figure 2.5. Measured changes in optical density of known bacterial suspensions using microfluidic platform with 
photodiodes.  The photodiode output is linearly correlated to turbidity measured with a spectrophotometer.   
There was a strong linear relationship (R
2
 = 0.98) between the actual bacterial 
density (OD600) and the optical density changes measured by the microfluidic platform.  
The data also highlighted key differences between the platform and a spectrophotometer.  
First, the change in optical density measured by the photodiodes maintained a linear 
relationship at high bacterial densities; standard spectrophotometers using traditional 
cuvettes with a 1 cm pathlength are known to respond nonlinearly at high OD600 values, 
necessitating dilution of the sample to a measurable concentration (OD600 < 0.5) and 
calculating the original optical density of the solution from that of the dilution.  The 
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nonlinearity seen with high turbidity solutions can be attributed to the low light 
transmission through particularly dense suspensions, as noise will dominate a low 
photodetector signal.  A smaller length scale will minimize the amount of light scattering 
through a dense suspension, fundamentally generating a dilution without manipulating 
the sample.  Smaller length scales also typically create a higher limit of detection; while 
the system appeared capable of distinguishing between OD600 values of 0.1 and 0.25, 
values less than 0.1 were not tested, and the detection limit of the system was not 
explored.  For the purposes of biofilm growth, a linear response at higher optical densities 
is more useful than the ability to measure very low concentrations of bacteria, as biofilms 
form quickly and involve higher concentrations of bacteria.  Additional factors to 
consider are the fundamental differences between the custom microfluidic platform and a 
spectrophotometer.  In addition to the different optical pathlengths, the LED array 
produces a wide range of optical wavelengths (a band of spectrum typically greater than 
20 nm wide), while the laser in a spectrophotometer produces a very narrow spectrum 
(typically less than 3 nm).  Furthermore, when measuring the optical density of a biofilm 
formed in the custom microfluidic platform, not only does the number of bacteria 
contribute to optical density, but incident light is also scattered by the biofilm-media 
interface.  While there are a number of differences between the microfluidic platform and 
a traditional spectrophotometer that impede direct comparison between the two methods, 
it is useful to have an approximate correlation between the techniques for comparing 
results from the microfluidic platform to those from standard biofilm studies.  
Additionally, such a correlation enables inexpensive, commercial off-the-shelf optical 
components to replace a more expensive spectrophotometer for optical density 
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measurement.  While a spectrophotometer is expected to have a higher degree of 
sensitivity due to its lower noise level, the LED and photodiodes are simple to implement 
and can be integrated with a variety of form factors beyond cuvettes and microwell 
plates.   
Small differences were evident in the outputs of two photodiodes positioned at 
different locations within the microfluidic channel; an example of this is provided in 
Figure 2.6a.  In this case, the output at the first window, closest to the inlet, showed more 
aberrations than the output of the second window.  In other cases, such differences 
between photodiode outputs were not as apparent, as shown in Figure 2.6b, indicating 
that, at least in this work, firm conclusions with regard to repeatability in changes in 
biofilm properties along the length of the channel cannot be drawn. 
 
Figure 2.6. Raw optical density change measurements corresponding to the output of the two photodiodes 
positioned under one microfluidic channel.  ‘Window 1’ is closest to the channel inlet.  Data correspond to two 
separate E. coli W3110 experiments.  a) Outputs differ along the length of the channel, as seen difference in 
photodiode outputs between 5 and 12 hours; the greatest difference between outputs is 31%.  b) Outputs show 
almost identical behavior with less than a 10% difference between measurement locations. 
When evaluating the average output of the two photodiodes, it was observed that 
the biofilm optical density exhibits unpredictable sharp increases and decreases, as shown 
in Figure 2.7a.  These ‘spikes’ reflect optical density changes faster than the doubling rate 
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of E. coli (< 10 minutes versus 20 minutes), and therefore cannot be attributed simply to 
natural bacterial growth.  It was hypothesized that this was due to both the non-uniform 
nature of the biofilms grown in the channel and the additional dynamics provided by the 
flow environment.  If a section of biofilm is sheared off, it can either reattach elsewhere 
along the channel, or exit the flow cell with waste growth media.  The location from 
which it was sheared off will exhibit a sharp decrease in biomass, and if redeposited, the 
location to which it adheres will exhibit a sharp increase in biomass.  If both detachment 
and reattachment locations were positioned over observation windows, there would be no 
observed change in average biofilm optical density, as the optical densities were averaged 
between photodiodes and over a period of 5 seconds.  However, if only one of these 
locations is positioned over a window, either a sharp increase or decrease in optical 




Figure 2.7. Data corresponding to E. coli W3110 and MDAI2 biofilms formed in two microfluidic platforms.  a) 
Raw optical density change measurements, illustrating unpredictable “spikes” in observed optical density b) 
Data from (a) smoothed using quadratic fits (Appendix C). 
In order to obtain a representative picture of the biofilm as a whole, as a biofilm is 
by definition a bulk phenomenon, data was either smoothed using quadratic fits (Figure 
2.7b, Appendix C), or evaluated only at the endpoint of growth.  While much data is lost, 
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elimination of this noise provides an adequate representation of the overall biofilm.  
Further analysis of the raw data, combined with other evaluation methods such as 
continuous microscopy, can further elucidate the roots of the observed fluctuations.  
2.1.4.2 Biofilm Sensitivity to Shear Stress 
One of the unique capabilities of this platform is real-time observation of the 
biofilm state without the bulk and expense of confocal microscopy.  This capacity was 
demonstrated through an experiment evaluating biofilms during exposure to shear stress.  
As biofilm thickness depends on the shear stress experienced by the biofilm (see Section 
1.3.1.2), the response of the biofilm to shear stress is reflected in its overall biomass, and 
consequently, its optical density.  
Biofilms were prepared according to the procedures of Section 2.1.2.3, using 
E. coli strains W3110 and MDAI2, and grown for 48 hours.  At this point in time, the 
flow rate was increased to 400 µL/hr for 30 minutes, then returned to the initial flow rate 
of 10 µL/hr.  Results of the high shear rinsing studies are shown in Figure 2.8.   
 
Figure 2.8. Rinsing of E. coli W3110 and MDAI2 biofilms measured by the change in optical density.  Data 
indicate the role of quorum sensing in physical robustness of biofilms.   
400 µL/hr 10 µL/hr 10 µL/hr 
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The continuous optical density measurements showed the biofilm sensitivity to 
shear imposed on the biofilms, emphasizing the real-time observation capability of the 
platform and measurement system.  Using two different strains of bacteria, one wild-type 
(E. coli W3110) and one deficient in quorum sensing (E. coli MDAI2), the role of 
quorum sensing in the mechanical stability of the resulting biofilm was highlighted.  The 
wild-type biofilm exhibited little change in optical density after rinsing, and during the 
rinsing period, fluctuations of less than 10% with respect to the initial optical density 
were observed.  In contrast, the E. coli MDAI2 biofilm exhibited sharp and erratic 
changes during the rinsing period and a larger overall change in optical density after 
rinsing as compared to before rinsing.  This is most likely due to the lack of 
exopolysaccharide production in quorum sensing-deficient strains of bacteria [5, 129]; 
the absence of a sufficient extracellular matrix may reduce biofilm cohesion and render 
the structure more susceptible to external forces, such as those imposed by fluid shear in 
the microfluidic channel.   
2.1.4.3 Evaluation of Biofilm Optical Density over Repeated Experiments 
Building upon the capacity of the developed platform for optical observation of 
biofilms, a set of more extensive studies of the optical density of biofilms was performed.  
Characterization of biofilm optical density growth curves and correlation of optical 
properties to morphological properties of the biofilm confirmed the applicability of the 
platform for scientific biofilm studies.  Here, the dependence of E. coli biofilm formation 
on quorum sensing was explored using the microfluidic platform for optical density 
monitoring.   
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In each experiment, three platforms were arrayed in parallel; one was inoculated 
with wild-type E. coli W3110, and two with MDAI2.  While LB media was flowed 
through all of the channels during growth, one of the channels inoculated with MDAI2 
was exposed to LB media with 30 µM AI-2.  During the operation of an experiment, the 
growth medium was refreshed every 12 hours for all biofilms to ensure viability of the 
AI-2 molecules and to maintain parallelism between concurrent experiments.  The optical 
density of biofilms contained in all three channels was continuously measured.  The three 
types of biofilms were grown for time periods of 12, 24, 36, 48, 60, or 72 hours, with 
n = 3 for each type of biofilm and for each growth period.  The biofilm optical density 
states at the end of each growth period were compared using a 30 minute average to 
provide a single value for comparison.   
The averages of optical density results from repeated experiments are shown in 
Figure 2.9.  The optical absorbance of the biofilms was shown to vary with respect to the 
degree of intercellular communication.  Wild-type biofilms exhibited an initial period of 
rapid growth within the first 12 hours of flow, while MDAI2 biofilms grown with and 
without extracellular AI-2 showed more gradual increases in optical density.  The 
different types of biofilms exhibited different overall changes in optical density; wild-
type biofilms were the most optically dense, while luxS-null biofilms were the least 
optically dense.  AI-2 addition appears to restore optical density to MDAI2 biofilms; this 
is reflected by the compiled data shown in Figure 2.9, where the mean optical density 
change of MDAI2 biofilms grown with AI-2 was approximately equal to wild-type 
biofilm optical density changes after 48 hours.  Restoration of the biofilm optical density 
phenotype by addition of AI-2 confirms the dependence of the biofilm formation on AI-2 
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within the system.  Optical density for all three types of biofilms observed also appeared 
to continue to increase at 72 hours and did not approach a steady-state value. 
 
Figure 2.9. Compiled data for the change from baseline optical density for each type of E. coli biofilm formed. 
n = 3 for each data point, presented as the average of all trials. Error bars correspond to one standard deviation 
of the trials. 
When evaluating the statistical significance of the differences between time points 
within one strain and between types of biofilms, the magnitude of optical changes over 
growth was not consistent between experiments, reflected in the overlapping error bars in 
Figure 2.9.  However, the relative differences between strains were more consistent 
between experiments.  Wild-type biofilms were consistently the most optically dense, 
MDAI2 biofilms were the least dense, and by adding AI-2 to the latter, density could be 
restored.  The percent difference between wild-type biofilms and MDAI2 biofilms grown 
with or without AI-2 was expressed as 
                 
       
   
, 
using the optical density change of the wild-type biofilm (ODw) as a reference for the 
optical density change of MDAI2 grown with or without AI-2 (ODx ).  Comparison of the 
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percent difference from wild-type biofilms yielded more statistically significant 
differences between biofilm types (Figure 2.10, Table 2.1). 
 
Figure 2.10. Compiled data for the percent difference from wild-type (W3110) biofilms for MDAI2 biofilms 
(blue circles) and for MDAI2 biofilms grown with AI-2 (red squares).  Error bars represent one standard 
deviation of the averaged data. 
Table 2.1. Table of p-values obtained through Student’s t-test for comparison of optical density change 
magnitude and for comparison of percent difference in optical density change between E. coli biofilm groups. 
 12 h 24 h 36 h 48 h 60 h 72 h 
W3110 versus MDAI2 0.0076 0.0129 0.0362 0.0108 0.0224 0.0510 
W3110 versus MDAI2 + AI-2 0.0547 0.1383 0.8478 0.8833 0.9043 0.8713 
MDAI2+ AI-2 versus MDAI2 0.1695 0.1247 0.0474 0.0129 0.0264 0.0586 
% Difference W3110/MDAI2 versus  
% difference W3110/MDAI2+AI-2 
0.4067 0.1755 0.0084 0.0017 0.0146 0.0768 
Differences are considered significant for p < 0.05; comparison of strains via percent difference from wild-type 
biofilms yields more statistically significant differences. 
2.1.4.4 Evaluation of Biofilm Morphology over Repeated Experiments 
In order to compare optical density studies to traditional morphological studies, 
the physical nature of the biofilms formed in the microfluidic platform were interpreted 
through confocal imaging and analysis of image stacks.  Using the output of COMSTAT, 
the mean biofilm thickness and roughness coefficient were also averaged between sets, 
shown in Figure 2.11a and Figure 2.11b respectively. 
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Over the windows imaged using confocal microscopy, the variances in thickness 
differed to a large extent.  In some cases where a thick biofilm did not cover the majority 
of the window, the standard deviation of the thickness could be as much as 100% of the 
average biofilm thickness.  An alternative metric for examining the spatial non-
uniformity of the biofilms formed is the roughness coefficient, as defined by Heydorn et 
al. and evaluated using COMSTAT [95].  This parameter is a dimensionless number 
representative of the percent variation in biofilm thickness.  As roughness coefficient 
trends within one channel were variable, as with the optical density, the values for all 
windows measured for one type of biofilm at one time point were averaged.  Results, 
shown in Figure 2.11b, indicated a large degree of variability between channels and a 
lack of significant differences between types of biofilms.  The results suggest that biofilm 
roughness has a minimal dependence on bacterial quorum sensing activity, although 
wild-type E. coli biofilms appeared to have average roughness values lower than those of 
the other two types of biofilms investigated, especially after 60 hours of growth.  
Additionally, the variation in the roughness coefficient, indicated by the error bars in 
Figure 2.11b, was smallest for all three groups at 72 hours.  This may be indicative of an 
approach to a steady-state biofilm as the biofilm structure settles to a smooth surface that 
will not be as prone to sloughing. 
The average thickness of the biofilms also showed the same overall trend as the 
changes in biofilm optical density (Figure 2.11a).  As with the trends in optical density, 
wild-type biofilms were the thickest, MDAI2 biofilms were the thinnest, and addition of 
AI-2 to the latter produced MDAI2 biofilms with thickness approaching that of wild-type 
biofilms.  The thicknesses of all the biofilms increased over time, with the most 
52 
 
significant increases occurring between 36 and 48 hours in W3110 biofilms and MDAI2 
biofilms grown with AI-2.  Thicknesses of biofilms (Figure 2.11a, Table 2.2) showed less 
irreproducibility over different experiments than the optical measurements (Figure 2.9) 
and roughness coefficient calculations (Figure 2.11b) for the same biofilms. 
 
Figure 2.11. Compiled morphological data, including a) average thickness, and b) nondimensional roughness 
coefficient, for each type of biofilm formed. n = 3 for each data point, presented as the average of all trials. 
Error bars represent one standard deviation of the averaged data. 
Table 2.2. Table of p-values obtained through Student’s t-test for comparison of thickness between E. coli 
biofilm groups. 
 12 h 24 h 36 h 48 h 60 h 72 h 
W3110 versus MDAI2 0.0271 0.0004 0.0010 0.0003 0.0008 0.0030 
W3110 versus MDAI2 + AI-2 0.0868 0.0024 0.0015 0.0088 0.0040 0.0380 
MDAI2+ AI-2 versus MDAI2 0.4218 0.0973 0.6558 0.0108 0.1456 0.0748 
Differences are considered significant for p < 0.05; comparison of strains via percent difference from wild-type 
biofilms yields more statistically significant differences. 
Both W3110 and MDAI2 formed optically detectable biofilms.  While MDAI2 is 
incapable of synthesizing AI-2 due to the lack of luxS expression, formation of biofilms 
by MDAI2 still occurred, albeit not as efficiently as formation of wild-type biofilms.  
This agreed with the work of other groups, who have found that while biofilm formation 
may be encouraged by quorum sensing, in the absence of quorum sensing bacteria may 
still form thin, sparse biofilms [56]. 
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Addition of AI-2 appeared to restore optical density and thickness to MDAI2 
biofilms so that these characteristics approached those of the wild-type biofilms.  
However, the onset of the restoration was not immediate, as shown in the optical data.  It 
is possible that the concentration of AI-2 used in these studies (30 µM) combined with 
the flow properties in microfluidics may not be sufficient to immediately restore wild-
type behavior.  While 20 µM of extracellular AI-2 has produced quorum sensing activity 
in suspended cultures of MDAI2 [130], the dynamics of the microfluidic reactor may 
require higher concentrations of AI-2 in the growth media. 
While the concentration of AI-2 throughout the media is assumed to be uniform at 
the channel inlet, laminar flow around the biofilm structure and bacterial uptake of AI-2 
will produce a non-uniform concentration profile throughout the channel.  Unlike the 
suspensions of MDAI2, the physical structure of the biofilm will also impede transport of 
AI-2 through the biofilm to bacteria at the substrate interface.  Therefore, AI-2 
concentrations that may restore quorum sensing activity in a suspended culture of 
MDAI2 may not produce the same activity in an MDAI2 biofilm formed in a 
microfluidic flow environment.  However, the microfluidic device is more clinically 
relevant than bacterial suspensions – not only can biofilms be formed in microfluidics, 
but biofilms can be grown with a continuous supply of fresh nutrients, similar to in vivo 
environments with flow of fluids containing a variety of metabolites.  In microscale 
environments within both microfluidic and in vivo spaces, the dynamics of flow and 
exposure of the biofilm to molecules within the flow are expected to vary significantly 
with dimensions of the growth space.  For future studies using AI-2 or pharmaceutical 
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agents for treating biofilms, the dimensions of the microfluidic reactor must be accounted 
for when translating work between studies.   
The changes in biofilm optical density from recorded baseline values for all three 
types of biofilms investigated appeared to continue increasing steadily at the end of the 
selected growth period of 72 hours.  Conversely, biofilm thicknesses did not appear to 
exhibit any distinct increase toward the end of the growth period; while longer 
experiments must be performed in order to confirm or reject the achievement of steady-
state thickness in biofilms by 72 hours, it was inferred that the optical density of a biofilm 
is a unique characteristic, independent of its thickness.  While biofilms may achieve a 
steady-state thickness, the structure may continue to reorganize itself over time, 
contributing to increased optical density.  These results correspond with those of Bakke et 
al. at the macroscale, in that a morphological steady state was achieved more quickly than 
an optical steady state [14].  
Biofilm thickness did not approach a distinct steady state within the allotted 
72 hour time period.  However, with a longer experimental duration, it is expected that a 
steady-state thickness would be reached.  The attainment of a steady state is expected 
given the bacterial growth behaviors observed in macroscale settings.  When bacteria are 
grown in any type of reactor, the growth rate is dependent on nutrient availability.  In 
suspension or in static reactors such as a microwell plate, the amount of growth media 
and nutrients is fixed; therefore, as metabolites are depleted, the bacteria will reach a 
stationary phase and, given further time, will begin to die [131].  In a flow reactor, there 
is a continuous supply of fresh nutrients, encouraging continuous and efficient bacterial 
growth.  However, as the biofilm forms on the bottom of the channel, the availability of 
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nutrients to the bacteria at the substratum becomes limited by diffusion through the upper 
portion of the biofilm, causing the growth rate to slow and eventually approach a steady 
state as a balance is achieved between thickness and nutrient diffusion.  Biofilm thickness 
is also limited by the shear stress imposed on the biofilm surface, since high amounts of 
shear will cause bacterial shedding.  This limiting effect is particularly pronounced in a 
microfluidic environment such as that constructed in this work; the small dimensions of 
the channel (100 µm deep) create an environment where as the biofilm grows to 
thicknesses of tens of microns, the biofilm itself affects the flow by decreasing the 
effective diameter of the microfluidic channel and thereby increasing shear stress.  
Through a negative feedback system, the bacteria will consume nutrients and divide in 
order to sustain the population but will maintain a thickness small enough for unimpeded 
flow through the channel (i.e. the channel does not become clogged with biofilm) [32].  
The combination of biological and physical phenomena is expected to produce the 
eventual steady-state thickness suggested by the data in Figure 2.11a. 
While additional experiments with longer time durations will clarify the dynamics 
of biofilm formation, it must also be acknowledged that the earlier time points are of 
particular interest.  In terms of the ultimate application of this platform for evaluation of 
drugs for biofilm prevention and eradication, focusing on early biofilm growth is of 
particular importance for prevention of serious biofilm infection.  Therefore, while it is of 
scientific interest to continue biofilm growth experiments for longer periods of time, such 
as the weeks-long experiments performed by Bakke et al. [14], if this platform were to be 
applied toward drug discovery and evaluation, long-term experiments are not essential. 
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2.1.4.5 Evaluation of the relationship between biofilm thickness and optical density 
Although it appeared that the relationship between biofilm morphology and 
optical density is not direct, especially considering the differing time scales of steady-
state approach, the likelihood of a relationship between the two was statistically 
investigated.  A linear correlation between the values for endpoint optical density and 
biofilm thickness (Figure 2.9 and Figure 2.11) yielded a correlation coefficient of 0.78.  
Considering the large number data points used to obtain this correlation (n = 54), this 
degree of correlation is significant and implies a strong association between the two 
variables.  While thickness and optical density are expected to be independent, a linear fit 
was generated using optical density as an independent variable and biofilm thickness at 
that time point as a dependent variable.  As shown in Figure 2.12, a linear fit of the 
thickness with respect to change in optical density yielded an r-squared of 0.9; due to the 
clustering of data at low optical density and thickness values, an intercept was imposed 
on the data, allowing for an improved fit.  Note that while the fit is improved, it is not 
directly physically relevant; here, at the onset of the experiment the thickness is predicted 
to be 6 µm.  The actual average thickness is expected to be much lower (< 1 µm), as the 
inoculum OD600 of 0.25 will not cover the entire floor of the microfluidic channel, and 
each cell will be less than 2 µm in height.  Further experimentation, especially at shorter 




Figure 2.12.  Least-squares regression fit of biofilm thickness (t) versus change in optical density (OD), compiled 
for all biofilms at all timepoints observed. R2 = 0.90198. 
The uncertainty of the change in optical density measurement is dependent on a 
number of factors, including errors introduced by the inherent properties of the 
measurement equipment, such as the photodiodes (dark current), data acquisition unit 
(analog input accuracy), and the measurement circuitry (offset introduced by the 
transimpedance amplifier).  As an example, data were used from the endpoint of an 
immature biofilm with a final optical density change of 0.01; this represents the minimum 
relevant change in optical density to be measured and is also the point where the most 
uncertainty will be introduced.  From the components of error and using the assumed 
biofilm, the experimental uncertainty evaluated as outlined in [132] was approximately 
0.06% of the overall change in optical density.  Note that this uncertainty does not 
account for natural variations in bacterial systems, and therefore the large variations in 
the data obtained in this work are most likely due to biological fluctuations.  In order to 
minimize this uncertainty, it would be ideal to perform more repetitions of the 
experiments to determine the trends in optical density and morphological changes during 
biofilm formation; this would additionally aid in the refinement of a model of biofilm 
optical density versus thickness. 
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Inclusion of other variables in the optical density model, such as substratum 
coverage and biomass, may produce an improved fit.  However, the objective is 
ultimately to utilize measurement of changes in optical density as a substitute for 
microscopic measurement of biofilm bulk properties.  The refinement of the simplified 
thickness versus optical density model eliminates the need for corroboration of optical 
density results using imaging to obtain morphological properties and would be 
instrumental in development of a completely integrated microfluidic platform for real-
time biofilm monitoring. 
2.1.5 Conclusion 
This section described the development of the first microfluidic platform utilizing 
optical density monitoring to assess biofilm formation.  Optical density measurement is 
continuous and noninvasive, capable of providing real-time information on biofilm state 
while preserving the biofilm throughout growth.  Due to their ease of implementation and 
low cost, multiple platforms were arrayed in parallel allowing for simultaneous 
experiments.  The devices and measurement methodology were used to evaluate 
differences in biofilms formed under varying degrees of quorum sensing activity.  The 
influence of quorum sensing on physical stability of biofilms was evaluated by 
monitoring optical density while imposing a high shear rate on the biofilms.  Biofilm 
growth evaluated via the change in optical density was also compared to the thickness 
measured via confocal microscopy.  Biofilms formed by E. coli incapable of quorum 
sensing molecule synthesis were less optically dense, thinner, and covered less surface 
area than wild-type biofilms.  Addition of quorum sensing molecules partially restored 
wild-type biofilm characteristics to non-communicating bacteria.  While the optical 
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density changes of each biofilm were shown to be quite variable, relative optical 
differences between different types of biofilms showed more reproducibility.  A linear fit 
was used as a preliminary model for relating observed optical density changes to biofilm 
thickness.  With further experimentation, this model will allow for replacement of 
microscopy with continuous, non-invasive biofilm evaluation via optical density 
measurement.   
2.2 Second Generation Device 
The platform and results presented in Section 2.1 demonstrated that optical 
density can be used for biofilm monitoring.  However, a number of questions were raised 
by the results, particularly when examining variability in the raw data.  Some temporal 
aberrations may be attributed to biofilm sloughing, where segments of biofilm may 
detach and exit the microfluidic channel, decreasing the average amount of biofilm in 
addition to locally decreasing the biomass at the location from which the segment 
detached.  Alternatively, these segments may be deposited elsewhere in the channel and 
continue to grow in the new location; in this situation, the local biomass at the origin of 
the segment decreases, but the average biomass within the channel is unchanged.  These 
two scenarios are significantly different, especially when evaluating an anti-biofilm 
treatment – a permanent decrease in total biomass indicates an effective treatment, while 
sloughing and re-deposition elsewhere in the channel indicates no change in the average 
biofilm state.  In a platform with only two observation windows, it is impossible to 
differentiate between these two scenarios if all that is observed is a local decrease in 
biomass.   
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In order to distinguish local changes from overall changes in biofilm, a platform 
with the capability of observing the entire microfluidic channel is required.  Considering 
this need, the platform presented in Section 2.1 was redesigned to replace the two 
individual photodiodes with a charge coupled device (CCD), essentially a linear array of 
photodiodes extending over the length of the microfluidic channel.  The CCD provided 
the capability of obtaining local optical information from each point in the array; the 
information obtained over the array was also averaged to reflect the overall biofilm state.  
The instrumentation, integration, and testing of the CCD with biofilm formation in a 
microfluidic channel was performed by Mr. Matthew Mosteller [126] as an extension of 
my development of the initial platform as summarized previously.   
2.2.1 Platform Design 
While an overview of the CCD-based microfluidic biofilm measurement platform 
and its implementation is presented here, specifics of the hardware and software involved 
therein are discussed in detail elsewhere [126].   
In general, the CCD-based measurement platform was similar in structure to that 
of the first generation platform, with a microfluidic channel placed on top of a transparent 
base with a patterned observation window aligned to a photodector.  The CCD used 
included a 128 x 1 linear array of photosensitive pixels, with each pixel measuring 
120 x 70 µm.  The array was positioned under a PDMS microfluidic channel temporarily 
bonded to a transparent substrate (500 µm-thick Pyrex®).  As in the first-generation 
device, CCD alignment to the channel and the LED light source was aided by metal 
(20 nm Cr under 200 nm Cr/Au) patterned on the transparent substrate.  In addition to 
defining the observation windows, the patterned metal was also used to apply electric 
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fields to biofilms for bioelectric effect studies.  Channels and CCDs were arrayed in 
parallel, as shown in Figure 2.13.  
 
Figure 2.13. Schematic of the CCD-based microfluidic biofilm observation platform.  A printed circuit board 
(PCB) served as a foundation for circuitry and electrical connections.  An array of microfluidic channels 
patterned in PDMS was placed on top of a transparent substrate and aligned to the underlying CCD array.  The 
platform depicted here also included electrodes patterned on the transparent substrate for applying an electric 
field to biofilms during growth.  Modified from [133]. 
As in assembly and testing of the first generation device, arrayed microfluidic 
channels and measurement circuitry were aligned to a light source and placed in an 
incubator maintained at 37 °C (Figure 2.14).  In this case, incident light for performing 
the optical density measurements was provided by an LED panel generating diffuse, red 
light.   
 
Figure 2.14. Schematic of experimental setup for CCD-based microfluidic biofilm observation platform.  The 
CCD array, microfluidic channel, and samples to be introduced into the channel were contained in a 37 °C 
incubator.  A syringe pump operating in withdrawal mode created sample flow in the microfluidic channels.  
External power supplies and function generators enabled actuation of the CCD sensors, while a DAQ card and 










The platform was used for biofilm studies using methodologies similar to those in 
Section 2.1.2.  After inoculation of the channels with a bacterial suspension, continuous 
flow of LB was applied during biofilm formation while optical density signals were 
continuously recorded.   
2.2.2 Results and Discussion 
The effectiveness of the CCD setup in providing details on spatiotemporal events 
in the microfluidic channel was demonstrated by flowing optically dense droplets (water 
dyed with food coloring with an OD600 ~ 45) in a transparent fluid (mineral oil) through 
the channel.  The average response of the CCD array, shown in Figure 2.15a, showed a 
series of peaks in optical density as droplets were introduced into and left the channel.  
Separating the average signal into the individual signals from each pixel in the array 
(Figure 2.15b) illustrated how pixels close to the entrance of the channel 
(position = 0 mm) measured the optical density increase of the droplet before pixels at the 
opposite end of the channel, the movement of the optical density peak down the position 






Figure 2.15. Demonstration of spatiotemporal optical density monitoring in the CCD-based microfluidic biofilm 
observation platform using flow of optically dense droplets in transparent mineral oil.  (a) Average change in 
optical density within one microfluidic chamber of the CCD-based biofilm measurement platform during 
droplet flow.  (b) Spatiotemporal detection of droplet flow within the same microfluidic channel. Reproduced 
from [126]. 
The same measurement methods used for droplet observation were expanded 
toward evaluating bacterial biofilm growth along the microfluidic channel.  Figure 2.16 
shows a sample spatiotemporal plot of biofilm growth, highlighting what were possibly a 
stationary biofilm segment (Figure 2.16a) and a segment of biofilm translocating down 
the channel over time (Figure 2.16b).  While the data shown in Figure 2.16 were not 
obtained from an untreated wild-type E. coli biofilm but one treated with an electric field 








Figure 2.16. Surface reconstruction of biofilm surface morphology showing (a) stationary biofilm and (b) biofilm 
drifting through the channel with time.  The surface reconstruction as created using the spatiotemporal data 
from optical density measurement using the CCD-based biofilm measurement system.  This particular plot is 
from a biofilm sample treated with an electric field.  Reproduced from [126]. 
2.2.3 Conclusion 
This section demonstrated the expansion of microfluidic biofilm optical density 
measurement into a format allowing higher spatiotemporal resolution of biofilm 
measurements.  Incorporation of a CCD array into a microfluidic biofilm formation 
platform not only provided average optical density measurements over the entire 
microfluidic channel, but through the resolution provided by an array of photosensitive 
pixels, was also able to provide insight into changes in the biofilm structure.  The ability 
to differentiate localized growth, detachment, and reattachment of biofilm in an 
integrated manner further advances the technique of optical density monitoring as a 
viable option for biofilm study.   
2.3 Chapter Summary 
This chapter covered the development of optical density monitoring as a 
measurement technique for evaluation of bacterial biofilm growth in a microfluidic 
environment.  The platforms developed through this work include the first, proof-of-
concept device delivering general information as to biofilm state, and the expansion of 
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this device to provide spatiotemporal details of biofilm dynamics.  Microfluidic biofilm 
reactors provide tight environmental control and small sample volumes, in addition to the 
ability of fabrication and parallel integration with optical measurement components at 
low cost.  These capabilities not only can be leveraged for scientific characterization of 
biofilms, as presented in this chapter, but also can be applied toward evaluating new anti-




3 Evaluating Effects of Quorum Sensing Inhibitors on Biofilm 
Formation 
This chapter will cover the application of the first-generation biofilm optical 
measurement platform developed in Chapter 2 for evaluating the effect of quorum 
sensing inhibitors (QSIs) on biofilm formation.  First, one such QSI, isobutyl-DPD, was 
demonstrated to inhibit the maturation of Escherichia coli biofilms grown in 
microfluidics.  Using optical density monitoring, it was shown that a combinatorial 
approach wherein isobutyl-DPD was used with near-MIC levels of the antibiotic 
gentamicin produced near complete clearance of pre-existing E. coli biofilms.  Similarly, 
another AI-2 analog, phenyl-DPD, also applied in combination with gentamicin, resulted 
in clearance of preformed Pseudomonas aeruginosa biofilms.   
As antibiotic-tolerant persister cells are a major contributor to the tenacity of 
biofilm infections, studies were performed to investigate a potential link between the 
biofilm inhibition and clearance instigated by QSIs, and the incidence of persister cells.  
The results of this investigation suggested that QSI administration to a bacterial culture 
has no significant effect on persister cell formation, although future investigation is 
warranted.  The work in this chapter was performed in conjunction with Dr. Varnika Roy 
as an equal contributor.  The majority of Section 3.1 has also been published in Applied 
Microbiology and Biotechnology with Dr. Varnika Roy as a co-first author [119].   
3.1 Evaluation of Quorum Sensing Inhibitors using Microfluidic Platform 
with Optical Monitoring  
The inhibitory effects of the QSIs studied were evaluated in two biofilm growth 
scenarios: application from the beginning of growth, and application to a preformed 
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biofilm after maturation.  The former demonstrated efficacy in biofilm prevention, and 
the latter demonstrated efficacy in clearing biofilms.  While the microfluidic platform 
provided dynamic, real-time measurements of biofilm density, studies were also 
performed in a microfluidic channel on an unpatterned glass coverslip (i.e. no observation 
windows patterned in chrome as in Section 2.1).  While the unpatterned substrate 
precluded real-time optical density measurement, it allowed more detailed confocal 
microscopy studies that provided strong physical evidence of biofilm clearance.  The 
combination of biofilm evaluation methods and growth scenarios produced detailed proof 
that the AI-2 based QSIs studied not only reduce biofilms, but also can potentiate the 
biofilm-clearing efficacy of traditional antibiotics.   
3.1.1 Methods 
3.1.1.1 Microfluidic Device Fabrication and Assembly 
Fabrication of the microfluidic platform was described in [118] and is also 
presented in Section 2.1.1; it is summarized again here.  The base of the device was a 
coverslip, a transparent substrate thin enough for high resolution inverted confocal 
microscopy.  For experiments with continuously measured optical density, coverslips 
were patterned with two observation windows in chrome (see Appendix A, Mask #1) to 
allow alignment of windows with embedded optics.  In experiments where confocal 
microscopy alone was used to evaluate biofilms formed throughout the channel (7 points 
in each channel were imaged), the coverslips were uncoated.  Although the elimination of 
the two windows precluded measurement of optical density using the methods of Chapter 
2, the information gained with confocal microscopy at more than two locations within the 
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channel provided more certainty in evaluating biofilm knockdown by a new QSI.  Optical 
density data was then used to corroborate these confocal microscopy results.   
The microfluidic channel itself consisted of polydimethylsiloxane (PDMS) 
molded by photopatterned Microchem SU8-50 (Appendix A, Mask #2).  Here, the mold 
produced microfluidic channels 100 µm deep, 500 µm wide, and 2 cm long.  Ports for 
interfacing the channel to fluidic tubing were punched into the PDMS using a 2 mm 
dermatological punch. The PDMS was reversibly adhered to the coverslip by soaking the 
bonded side of the PDMS in methanol for 1 minute, then aligning and placing the section 
of PDMS over the coverslip. 
3.1.1.2 Biofilm Formation 
Biofilms were formed either by E. coli K-12 MG1655 ATCC #47076, or by P. 
aeruginosa PAO1.  For both strains, overnight cultures were diluted to an OD600 of 0.25, 
introduced into the microfluidic channel, and incubated with no flow at 37 °C for 2 hours.  
Luria Bertani (LB) growth medium was then continuously suctioned from a 
microcentrifuge tube reservoir into the device at a rate of 10 µL/hr.  As needed, this 
medium was supplemented with various concentrations of analog or antibiotic at 
specified times.  In studies of biofilm inhibition, after 2 hours of cell incubation, the 
analog diluted in LB medium was flown into the microfluidic channel for 48 hours at 
10 µL/hr.  In studies of effects on preformed biofilms, LB was introduced over the cells 
at 10 µL/hr for a period of 36 to 48 hours to yield stable biofilms.  Then, the analog or 
analog-antibiotic combination was introduced for an additional 36 to 48 hours.  In all 
experiments, growth medium was refreshed every 12 hours for all biofilms by replacing 
the used reservoir with one containing fresh LB or a freshly prepared solution of LB and 
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analog or antibiotic.  This procedure was implemented to prevent potential QSI 
degradation and maintain parallelism between concurrent experiments.   
3.1.1.3 Biofilm Staining and Confocal Microscopy 
Biofilms were stained in situ for microscopy.  They were first treated with a 
Live/Dead bacterial labeling kit (Invitrogen #L7012) in which two labeling components 
were mixed in a 1:1 ratio to a final volume of 10 µL.  The dye was introduced into the 
channel at 10 µL/hr, the same flow rate as during biofilm growth.  This treatment was 
then followed by 10 µL/hr flow of 100 µg/mL of calcofluor (Fluorescence Brightener 28, 
Sigma Aldrich #F3543) in deionized (DI) water for labeling polysaccharides contained in 
the biofilm matrix [134].  The dyes were fixed by flowing in 3% paraformaldehyde at the 
same flow rate.   
Labeled samples were imaged using a confocal microscope (Zeiss LSM710).  For 
unpatterned coverslips, Z-stacks were obtained at 7 points in each microfluidic channel, 
with each stack containing 150 image slices.  For patterned coverslips used while 
measuring the optical density of the biofilms, two image stacks were obtained in each 
channel (i.e. one at each observation window).  The image stacks were analyzed using 
COMSTAT [95], which provided morphological characteristics.  Biofilm thickness and 
biomass were averaged over the image stacks obtained at each point in the microfluidic 
channel.  While other parameters may be investigated via COMSTAT, these two features 
were deemed most representative of the changes observed in these studies.  Additionally, 
surface reconstructions of the biofilms were created using Imaris (Bitplane, Inc.) to aid in 
visualization of the resulting structures. 
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3.1.1.4 Optical Density Measurement and Analysis 
While confocal microscopy is extremely effective for characterizing bacterial 
biofilms, especially in conjunction with analysis software such as COMSTAT [95] and 
Imaris, implementing this method requires extensive sample preparation and imaging 
time; the staining and imaging performed in this study required up to 12 hours of time 
added to the experiment itself.  In addition to the benefits provided by the microliter-size 
channel volume, microfluidic biofilm reactors also possess the ability to integrate precise 
biofilm measurements with the fluidic operation of the device.  In this work, the 
microfluidic reactor was integrated with continuous optical density measurement [118] to 
dynamically evaluate the synergistic influence of AI-2 analog and antibiotic on 
preformed biofilms. 
The data corresponding to the change in optical density of the biofilms were 
obtained from the photodiodes using the methodologies described in Chapter 2.  
However, the methodology for analyzing the raw optical density data was updated to aid 
in understanding the trends and to account for device-to-device variations.  As optical 
density measurement was used only to evaluate QSI effects on preformed biofilms, data 
for each channel (the average of the response of the two photodiodes) was normalized 
with respect to the optical density at the time treatment was introduced (48 hours).  This 
method reflects that as of the time of introduction, the biofilms were grown under 
identical conditions although their optical density values may not be identical due to 
device-to-device variations in biofilms.  In a system such as a spectrophotometer, a high 
optical density such as that of a mature, 48 hour biofilm, is expected to yield a non-linear 
response.  However, normalization to the biofilm state at 48 hours was considered to be 
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appropriate for this particular microfluidic platform due to the linearity seen at high 
OD600 values in the photodiode output, as discussed in Section 2.1.3.1.   
Since the optical density data itself fluctuates as the biofilm grows, as discussed in 
Section 2.1.4.1, the data for each curve was fitted in Origin (Origin Lab Corporation) 
using a Churchill model [135].  The Churchill model, while intended for application 
toward batch cultures, was used here to approximate the similar growth and death phases 
of a biofilm.  The model is represented by 
     [  
     
  ]     (3.1) 
Here, N represents the biomass; in this case, it was assumed to be directly correlated to 
the optical density.  f1 and f2 represent the growth and death of the culture, respectively, 
and can be expressed in a generalized form as 
              (3.2) 
                  (3.3) 
When the model was fitted to the raw data, overall trends were represented, as 
shown in the sample data from Figure 3.1a.  However, the occasional sharp fluctuations 
in optical density heavily influenced the fitted curve – while the biofilm at one 
observation window may become suddenly much more optically dense than the other due 
to natural fluctuations, the average of the two windows also changes sharply, but is not 
indicative of the overall behavior of the biofilm.  To minimize the effects of sharp 
fluctuations, the Churchill model was also fitted to data points representing 6 hour optical 






Figure 3.1. Analysis of optical density curves and fits using E. coli biofilm growth data (a) Normalized change in 
optical density; raw data (dotted line) was normalized with the change in optical density at 48 hours set to be 1.  
The curve was fit (solid line) using a Churchill model.  (b) Adjusted curve fit, using a fit to data averaged every 6 
hours (squares).  The curves have also been adjusted to reflect a zero change in optical density at the beginning 
of growth. 
 
3.1.2 Results and Discussion 
3.1.2.1 Biofilm Maturation in the Presence of AI-2 Analog 
The effect of the analog on biofilm growth was tested by continuously exposing 
the cells to analog diluted in LB.  As summarized in Figure 3.2a, perfusion of LB media 





 by the end of the incubation period (48 hours).  The presence of 40 µM 
isobutyl-DPD inhibited the biofilm growth by approximately 70%, yielding films 7 µm 




.  Increasing the analog concentration to 100 µM had 
no further inhibitory effect on biofilm thickness.  Surface rendering images of the 
biofilms confirmed that without isobutyl-DPD exposure, the biofilm was much thicker 
and more structured (e.g. more void space, microchanneling, larger groupings of live and 
dead cells, Figure 3.2b).  The presence of analog in both 40 and 100 µM concentrations 
yielded biofilms more like thin bacterial carpets (Figure 3.2Figure 3.2c, d).  A striking 
difference however, was found between the isobutyl-DPD treated cultures.  The biofilm 
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with 100 µM isobutyl-DPD appeared sparser and had less surface coverage than the 
biofilm exposed to 40 µM isobutyl-DPD.  Moreover, nonviable cells were virtually 
absent and a preponderance of polysaccharide was found.  These morphological 
differences are evident in the surface reconstructions presented in Figure 3.2b-d.   
 
Figure 3.2. Analysis of 48 hour E. coli biofilm thickness and architecture in response to isobutyl-DPD.  a) 
Thickness and biomass of biofilm analyzed by COMSTAT (average of four different points).  b–d) 
Representative Imaris 3D surface reconstructions of the biofilm with b) LB only, c) LB+40 μM isobutyl-DPD, d) 
LB+100 μM isobutyl-DPD.  Images were selected from locations with average thicknesses and biomasses closest 
to the average of all points analyzed. 
While the AI-2 analogs did not directly kill the bacteria, the interference in the 
mechanisms involved in forming a biofilm (e.g. motility [15] and extracellular matrix 
secretion [56, 129]) appeared sufficient for inhibition of a stable, three-dimensional 
biofilm architecture.  Lacking the structural cohesiveness of an extracellular matrix 
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produced with the aid of native quorum sensing [56], biofilms treated with large analog 
concentrations were potentially more susceptible to delamination.  As non-viable cells 
have weaker substrate adhesion than viable cells, they are more likely to delaminate in 
the absence of a cohesive polysaccharide matrix.  This hypothesis was supported 
particularly by the results in Figure 3.2d; after growth with 100 μM isobutyl-DPD, 
nonviable cells were removed from the biofilm polysaccharide matrix.  Conversely, the 
remaining polysaccharide matrix that was not able to retain these cells maintained 
adhesion to the substrate.  Irrespective of these polysaccharide and Live/Dead assays, 
results clearly demonstrated that isobutyl-DPD, a known inhibitor of QS responses in E. 
coli [84], can also decrease biofilm formation by E. coli . 
Compared to untreated biofilms, biofilms treated with AI-2 analogs throughout 
growth were thinner and less ordered as noted by an apparent lack of cohesive 3D 
structure, such as mounds.  QS inhibitors, while not bactericidal, can mitigate biofilm 
formation by inhibiting bacterial communication, thereby restricting expression of genes 
related to biofilm formation [56, 136].  This suggests that the bacteria within a nascent 
biofilm might phenotypically be more similar to bacteria in suspension.  Biofilms grown 
here, while continuously supplemented with AI-2 analogs, showed decreased formation 
even without additional antibiotic.   
3.1.2.2 Effects of Analog on Preformed E. coli and P. aeruginosa Biofilms 
The phenotypic changes in biofilms continuously exposed to a QSI spurred 
interest in whether the analog could alter existing biofilms.  As isobutyl-DPD is an 
established QS quencher, it is neither bacteriostatic nor bacteriocidal among planktonic 
cells [84].  Thus, if isobutyl-DPD were used to treat the bacteria and the pathogenic 
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bacterial populations were not removed from the host, an infection would persist.  As the 
biofilms described in Section 3.1.2.1 appeared to persist after continuous exposure to 
isobutyl-DPD, seen in their thinner and more porous structures, it was hypothesized that 
antibiotic co-administration could be more effective in eventual eradication of biofilm.   
In order to test this approach, combinations of gentamicin (5 µg/ml) with 
increasing concentrations of isobutyl-DPD (40 µM and 100 µM) were used to treat pre-
established E. coli biofilms.  The control biofilm, exposed to LB medium only, exhibited 




 (Figure 3.3a).  
Addition of gentamicin without AI-2 analog decreased the thickness slightly to 10 µm, 




).  However, addition of antibiotic and 
analog (40 µM isobutyl-DPD) decreased the average biofilm thickness to 6 µm (Figure 
3.3a).  Most importantly, this study showed that 100 µM isobutyl-DPD used with 
gentamicin was the most effective in clearing the preformed biofilm, shown by the 
reduction in thickness by more than 80% to an average of 2 µm and by the nearly 
complete removal of biomass.  The 3-D surface rendering images confirmed 
morphological data (Figure 3.3b-e), as the biofilm surface thickness decreased 
significantly in the presence of both isobutyl-DPD and gentamicin.  With 100 µM of 




Note: Biofilms were formed for 36 hours, then analog and antibiotic were flown over the preformed biofilm for another 
36 hours. 
Figure 3.3. Analysis of effect of combinatorial approach analog and gentamicin on preformed E. coli biofilm 
thickness and architecture.  a)Thickness and biomass of biofilm analyzed by COMSTAT (average of five 
different points in the channel).  b–e) Representative Imaris 3D surface reconstructions of the biofilm with b) LB 
only, c) LB+5 μg/mL gentamicin, d) LB+40 μM isobutyl-DPD+5 μg/mL gentamicin, e) LB+100 μM isobutyl-
DPD+5 μg/mL gentamicin.  Images were selected from locations with average thicknesses and biomasses closest 
to the average of all points analyzed. 
QS quenching activity of P. aeruginosa by some C1-alkyl analogs, phenyl-DPD 
in particular, has been observed [85].  Considering the reduction of preformed E. coli 
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biofilms upon application of isobutyl-DPD with gentamicin, a combination of phenyl-
DPD (100 µM) and gentamicin (5 µg/ml) was applied to pre-existing P. aeruginosa 
biofilms, analogously to the E. coli experiments.  When treated with a combination of 
phenyl-DPD and gentamicin, P. aeruginosa biofilms became far more thin and more 









, Figure 3.4a).  These results were corroborated by qualitative evaluation of 
the images obtained through surface rendering of confocal microscopy results (Figure 
3.4b-e).  Biofilms grown without the addition of phenyl-DPD showed denser surface 
coverage and appeared more structured than biofilms grown with phenyl-DPD.  The P. 
aeruginosa biofilms treated with both phenyl-DPD and gentamicin, similar to E. coli 




Note: Biofilms were formed for 36 hours, then analog and antibiotic were flown over the preformed biofilm for another 
36 hours. 
Figure 3.4. Analysis of effect of combinatorial approach analog and gentamicin on preformed P. aeruginosa 
biofilm thickness and architecture.  a) Thickness and biomass of biofilm analyzed by COMSTAT (average of 
five different points in the channel).  b–e) Representative Imaris 3D surface reconstructions of the biofilm with 
b) LB only, c) LB+5 μg/mL gentamicin, d) LB+100 μM phenyl-DPD, e) LB+100 μM phenyl-DPD +5 μg/mL 
gentamicin.  Images were selected from locations with average thicknesses and biomasses closest to the average 
of all points analyzed. 
In the experiments performed on biofilms continuously exposed to a QSI from the 
beginning of growth, it was demonstrated that a QSI could inhibit biofilm formation.  
Here, it was also observed that application of QSIs to a mature biofilm also decreased its 
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thickness and biomass compared to untreated biofilms.  When AI-2 analog was 
supplemented with gentamicin, the biofilms were almost completely removed, 
presumably because they were more susceptible to antibiotic exposure.  The above 
experiments, for the first time, demonstrated the effectiveness of AI-2 analogs in 
decreasing the growth of E. coli and P. aeruginosa biofilms. 
This study highlighted the importance of a QSI and antibiotic combinatorial 
therapy as being more effective than antibiotics alone in significantly clearing both E. 
coli and P. aeruginosa preformed biofilms.  Of note is the concentration of gentamicin 
used in this work, 5 g/mL, specifically selected to be on the same order of the 4 g/mL 
MIC for E. coli K-12 [137].  Gentamicin MIC values for P. aeruginosa PAO1 have been 
reported from 2 to 6.25 g/mL [138].  The effects on biofilms seen here are created by 
antibiotic concentrations within the normal planktonic culture-derived MIC values, which 
in turn, are expected to be much lower than needed for biofilms [121, 139].  That is, 
standard inhibitory antibiotic doses for planktonic cultures were applied combinatorially 
with AI-2 analogs and were able to clear preformed biofilms in the microfluidic channels.  
The augmentation of the antibiotic or anti-biofilm effects of gentamicin by co-
administration with AI-2 analogs is significant because it could lead to dispersal of 
biofilm infections with sub-MIC levels of antibiotics, thereby preventing destruction of 
the native microflora. Second, the use of lower concentrations of antibiotics can 
potentially delay the emergence of resistant strains.  Also, for existing antibiotics with a 
narrow therapeutic window due to toxicity to the host, a strategy to lower the MIC or 
synergistically aid the antibiotic to clear biofilms at lower concentrations would expand 
the applicability of these antibiotics.   
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3.1.2.3 Investigation of Live/Dead Proportions 
The Live/Dead staining kit used is designed so that SYTO9, which fluoresces 
green, stains the DNA of both viable and unviable bacteria.  Propidium iodide (PI) stains 
the DNA of only unviable bacterial cells with damaged cell membranes; as PI has a 
higher degree of fluorescence intensity than SYTO9, its signal dominates over the 
SYTO9 signal generated by stained unviable cells.  In theory, exposure to antibiotic kills 
more bacteria and produces more PI-stained cells.  As posited previously, exposure to an 
AI-2 analog inhibits EPS production, possibly allowing for the release of nonviable cells 
from the biofilm since they have a weaker degree of adhesion than healthy bacterial cells.  
Therefore, it is conceivable that a biofilm may be characterized by the ratio of red to 
green fluorescent cells, indicative of the health of the biofilm when taken into 
consideration with the biofilm’s average thickness.   
In order to investigate the potential for biofilm characterization via live : dead 
ratio, the confocal images obtained for the above studies were analyzed for viable cell 
content, using the volumetric ratio of red fluorescent to green fluorescent cells obtained 





Figure 3.5. Comparison of Live/Dead percentages in confocal images presented in Figures 3.2-3.4, reflecting the 
effect of continuous E. coli biofilm exposure to isobutyl-DPD (Figure 3.2), and exposure of preformed E. coli 
(Figure 3.3) and P. aeruginosa (Figure 3.4) biofilms to gentamicin and isobutyl-DPD or phenyl-DPD.  Each bar 
represents one imaged location within the channel.  Results were expected to show a decrease in unviable cells 
with addition of DPD analogs, indicative of a weaker extracellular matrix; as shown, actual results obtained 
were inconclusive. 
No clear deductions can be made from Figure 3.5.  In the case of the data obtained 
from image stacks presented in Figure 3.2 (the first 3 bars), addition of analog decreased 
the unviable cell composition as expected.  However, in the data from Figure 3.4 (the last 
4 bars), addition of analog or of antibiotic had little effect on the unviable cell 
composition, and combinatorial addition of both increases the unviable cell composition.   
Although the concentrations of stains are developed by the manufacturer to be 
applicable to the majority of strains of bacteria, irregular staining or false signals are still 
possible depending on a number of factors, including the metabolism of the bacterial 
culture and thoroughness of rinsing after stain application [140, 141].  If the 
Figure 3.2 Figure 3.3 Figure 3.4 
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viable : unviable cell ratio is to be used as a metric for biofilm health, extensive 
characterization of the stains and staining protocol for the strains and conditions used 
must be performed.  For the purposes of these studies, no quantitative conclusions were 
drawn from the amount of viable and unviable cells within a biofilm, and both types of 
stained cells were considered as a lumped element of biomass.   
3.1.2.4 Leveraging Microscale Reactor for Streamlined Measurement 
Optical density measurement using the device with the patterned base, as in 
Chapter 2, was used to gather data from both E. coli and P. aeruginosa biofilms treated 
with the analog-antibiotic combinatorial approach.  Dynamic analysis of replicate 
windows revealed a complex non-uniform process that when fitted to a mathematical 
model suggested relatively uniform biofilm growth overall for the first 48 hours, at which 
time, divergent behaviors were observed based on small molecule addition (Figure 3.6a, 
c).  For E. coli (Figure 3.6a, b), biofilm growth was similar over the first 48 hours 
between the three experimental groups grown under identical conditions over that period.  
After 48 hours and initiation of treatment to two of the channels, the biofilm progression 
deviated with the most dramatic departure being the combination of isobutyl-DPD and 
gentamicin.  For P. aeruginosa, effects were roughly similar, although gentamicin alone 
was less effective when comparing optical density and thickness (Figure 3.6c, d).  In all 
cases, however, the addition of gentamicin with a QSI after 48 hours slowed the progress 
of biofilm maturation relative to the controls, resulting in diminished films by the end of 




Figure 3.6. Analysis of effect of combinatorial approach on optical density and thickness using analog and 
gentamicin on E. coli (a, b) and P. aeruginosa (c, d) biofilms preformed for 48 hours.  a) Normalized change in 
optical density of E. coli biofilms; raw data (dotted lines) were normalized with the change in optical density at 
48 hours set to unity.  Curves were fitted (solid lines) using a Churchill model [135].  b) Thickness and biomass 
of E. coli biofilm analyzed by COMSTAT (average of two points in the channel).  c) Normalized change in 
optical density of P. aeruginosa biofilms; raw data (dotted lines) were normalized and fitted (solid lines) using a 
Churchill model.  d) Thickness and biomass of P. aeruginosa biofilm analyzed by COMSTAT (average of two 
points in the channel). 
While the optical data in Figure 3.6a, c are presented as discrete and averaged 
values, in actuality, a large amount of information was gathered from the two 
photodiodes.  By observing the temporal variance in the response (Figure 3.7), the state 
of the biofilm and temporal disturbances were evaluated.  It was noted that for continuous 
optical measurements over the two observation windows, the standard deviation in the 
optical density values was typically less than 10% of the average after initial biofilm 
growth, as seen after the first 24 hours of P. aeruginosa biofilm growth in the sample 
data in Figure 3.7.  The internal consistency of the spatial and temporal variation in 
84 
 
biofilm optical density added to the reliability of the trends in optical data observed for 
such a small sample volume.  It was noted, however, that increasing the number of 
observation windows as in the second generation device in Section 2.2 would enable 
greater resolution of the area-based heterogeneity of the film. 
 
Figure 3.7. Box-and-whiskers plot of the control group (LB) in Figure 3.6c, demonstrating the temporal 
variability observed through optical density monitoring.  Each square represents the optical data averaged 
between two windows and averaged over 6 hour time windows centered at each point (endpoints are averaged 
over 3 hours).  Middle horizontal lines represent the median, and top and bottom horizontal lines represent ±1 
standard deviation of the data.  Minimum and maximum points within the data sets are denoted by an “x”. 
3.1.3 Conclusion 
The use of a microfluidic testing environment with small sample volumes made 
this investigation of QSI impact on biofilm formation possible. The integration of optical 
measurements in a dynamic and controllable environmental setting allowed for 
evaluating the “instantaneous” state of the biofilm.  This contrasts with the sole use of 
microscopy, which only permits an endpoint measurement.  Therefore, the use of this 
microfluidic setup revealed phenotypic data which normally would have been lost had 
only endpoint measurements been used.  Obtaining as much information as possible is 
especially important considering that the formation of a biofilm itself is highly variable.  
This is evidenced by the degree of variance in optical density observed over time.  By 
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tracking discrete points throughout biofilm growth and treatment, not only is the 
timescale of the contribution of the analog and antibiotic synergism toward biofilm 
reduction clarified, but additional information as to the instantaneous biofilm state and 
stability is gained.  The methodology implemented here thereby promotes a more 
complete understanding of the temporal and spatial variance in biofilm growth. 
In the translation of this work to clinical application, parameters obtained from 
the in vitro device that enable prediction in vivo or in other clinical situations would be 
valuable.  The flow conditions, for example, that are imposed on biofilms within our 
device create shear stress levels similar to those found in interstitial fluid [142].  Shear 
stress, along with the bacterial strain, growth media, and materials used to construct the 
microfluidic channel, may all be adjusted to more closely mimic the environments in 
which biofilms typically form infections [143].  Also, owing to the microscale 
confinement imposed by this system, another physical parameter, biofilm thickness, 
might be a good predictor of in vivo behavior.  Dental biofilm thicknesses have been 
shown to grow to approximately 50 μm after 1 week [144], while mature biofilms 
recovered from urinary catheters can range between 3 and 490 μm, depending on the 
formative species [145].  A mouse model of thermal injury showed mature, 11 μm-thick 
P. aeruginosa biofilms at 46 hours [146].  While the biofilms formed may be thin, the 
infections formed in this type of model are typically fatal within 48 hours [147].  
Combining these models with the fact that biofilms produced in this work range from 25 
to 40 μm within 48 hours, this microfluidic platform is capable of producing biofilms 
within the appropriate ranges for extension to clinical environments.  Also, the novel 
combinatorial treatment, as presented in this work, is ideally suited toward expanding the 
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range of physiological, chemical, and physical parameters needed to most accurately 
mimic in vivo systems. 
3.2 Effect of Quorum Sensing Inhibitors on Persister Cells 
The major knockdown of biofilm formation produced by QSIs applied in 
conjunction with antibiotics raised a number of questions as to the mechanisms by which 
the biofilm was reduced.  As discussed in Chapter 1, antibiotic-tolerant bacterial persister 
cells are a major contributor to the formation of chronic biofilm infections; one 
hypothesis for the effectiveness of the synergistic treatment was that the mechanism of 
biofilm inhibition was related to a possible knockdown in the number of persister cells.  
While unpublished studies mentioned in a review by Lewis indicate quorum sensing most 
likely has no effect on persister cell formation [54], two different persister assays were 
performed on cells exposed to a QSI in order to evaluate potential effects of QSIs on 
persister cells.  
3.2.1 Methods 
3.2.1.1 Culture Conditions and Persister Isolation 
Persister assays were performed on E. coli K-12 MG1655 ATCC #47076 using a 
colony forming unit (CFU) assay adapted from [148].  Normally, persister cells are 
formed in suspension cultures of bacteria by treating the culture with a high dose of 
antibiotic.  All the cells are killed except for the persisters, which are genetically identical 
to the cells that were killed, but are simply dormant.  To perform the assay, an overnight 
culture of E. coli was grown in LB media at 37 °C and 200 rpm.  1 mL of the overnight 
culture was re-inoculated in 50 mL of LB media, and the suspension was allowed to grow 
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to an OD600 of approximately 0.5.  The suspension was centrifuged at 750 rpm for 
15 minutes, then resuspended in LB media to yield a suspension of OD600 1.0.  The 
resulting suspension contains cells in exponential phase, but at an artificially high 
concentration.   
Samples of these cells were treated for 24 hours under four conditions: control (no 
treatment), 100 µg/mL gentamicin, 100 µM isobutyl-DPD, and 100 µg/mL gentamicin 
with 100 µM isobutyl-DPD.  Within an experiment, replicates were performed for each 
of these four groups.   
3.2.1.2 Assessment of Persister Cell Populations 





prepared from all groups and plated on LB agar plates containing 50 µg/mL gentamicin.  
After 24 hours, colonies on the plates were counted; the number of colonies is indicative 
of the number of CFU remaining after the four treatments were administered.  After 
exposure to high doses of antibiotic, colonies are only formed by persister cells able to 
withstand such treatment.   
In addition to the CFU assay, samples of cells were treated with a Live/Dead 
bacterial labeling kit (Invitrogen #L7012) for examination with fluorescence automated 
cell sorting (FACS) to determine the percentage of live cells in treated cultures.  While 
FACS is not a traditional method for evaluating persister cell populations, after treatment 
with a high dose of antibiotic, most cells should be dead except for a small number of 
persisters, whose intact cell membranes will allow for fluorescent staining as “live” cells.  
FACS samples were prepared by centrifuging 250 µL samples from each culture at 
750 rpm for 15 minutes.  The supernatant, presumably consisting of spent LB growth 
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media, was pipetted out and replaced with the same volume of phosphate buffered saline 
(PBS).  Cells were resuspended in the solution, and treated with the Live/Dead staining 
kit according to the datasheet, which specifies 3 µL of total dye solution (consisting of a 
1:1 ratio of SYTO9 to propidium iodide) for a 1 mL bacterial suspension.  Dye was 
mixed thoroughly with the suspension, and incubated in the dark for 15 minutes.  Stained 
samples were fixed with 3% paraformaldehyde in a 1:1 ratio of sample to 
paraformaldehyde.   
3.2.2 Results and Discussion 
The results, including details of replicates within the colony forming unit assay 
and the FACS study, are shown in Figure 3.8.  Note that colonies were counted on plates 
with higher dilutions (denoted below x-axis) for groups with no antibiotic administration, 
as the high number of CFU plated at high dilutions yielded a number of colonies so large 
that colonies often merged together.   
a) b) 
 
Figure 3.8. Results from persister cell formation experiments.  In both (a) and (b), the first column was 
untreated, representing a control in which many colonies are expected; similarly, the third column was treated 
only with isobutyl-DPD, which does not cause cell death.  The second column and fourth columns respectively 
represent generation of persister cells via treatment with a high concentration of antibiotic and the addition of 
analog to this treatment. Groups 1 and 2 are replicates. (a) Data from counting colonies formed after plating 
treated suspensions.  (b) Data obtained via FACS. 
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There was a large amount of variation between replicates, making it difficult to draw 
definitive conclusions.  While most likely unrepresentative of the true biological results, 
averages of the two replicates in both assays were taken to aid in data interpretation.  
These data are shown in Figure 3.9.  
a) b) 
 
Figure 3.9. Data from Figure 3.8, where each bar is an average of Group 1 and Group 2 as presented in Figure 
1.  (a) and (b) correspond to the data from Figure 3.8a and 3.8b respectively.  As the data are the average of two 
data points, standard deviations are not presented.   
Examining the averages, the results for the control were expected, in that there 
were many live, intact cells capable of forming colonies.  Additionally, the large number 
of CFU and live cells in the group treated with only isobutyl-DPD were also expected, as 
isobutyl-DPD does not kill the cells at the concentration used.  Note that in these cases, 
plates with higher dilutions were used, as individual colonies could not be counted on 
plates inoculated with low dilution cultures.  In general, the groups to which gentamicin 
was added also yielded expected results, since there were fewer live cells.  These live 
cells represent the population of persister cells.  However, the addition of analog 







As discussed in Chapter 1, there are mentions in literature of unpublished studies 
indicating quorum sensing has no influence on persister cell formation [54].  It is possible 
that there may be an indirect relationship between quorum sensing and persister cells that 
the experiments here and in literature cannot elucidate, as AI-2 is linked to intracellular 
enzymatic pathways through a complex network.  Additionally, QSIs may also influence 
cellular pathways outside of the intended targets.  For example, Pan et al. showed that 
some synthetic brominated furanones, inhibitors of AI-2 based quorum sensing and 
biofilm formation, reduce the incidence of persister cells of P. aeruginosa PAO1 [149].  
However, this restoration of antibiotic sensitivity was also independent of the QS 
inhibition that the brominated furanones are associated with.  Considering the complexity 
of both quorum sensing and biofilm formation, along with the ongoing characterization 
of the AI-2 analogs used here, extensive studies beyond the preliminary work here must 
be designed and performed in order to clarify the relationships between these analogs, 
biofilm formation, quorum sensing, and persister cells.   
3.3 Chapter Summary 
This work demonstrated several key findings.  First, biofilm development was 
inhibited by continuous application of AI-2 analogs.  Second, combination of these 
analogs with sub-MIC gentamicin concentrations enabled removal of preformed biofilms.  
While the precise mechanisms of biofilm clearance in the presence of analogs remains 
unclear, initial experiments indicated a lack of connection between analog exposure and 
persister cell elimination.  In terms of the goals of the dissertation, what was most 
important was application of the microfluidic observation platform developed in Chapter 
2 to provide critical information about short-range biofilm changes in response to 
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administration of a new antimicrobial under test.  As a whole, the work demonstrated 
both the success of the platform when used as a pharmaceutical testbed, as well as the 
potential to enable significant advances in bacterial biofilm science.    
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4 Development of Multi-depth Microfluidics for Controlled 
Biofilm Studies  
This chapter covers the development of a device designed to address the 
variability in biofilm formation between devices observed in the studies presented in 
Chapter 2.  The new device also streamlined performance of multiple parallel 
experiments.  The platform was designed to segment bacterial biofilms in one 
microfluidic channel for multiplexed experiments and promotion of experimental control.  
Sectioning was achieved by integrating hydraulically actuated valves into the 
polydimethysiloxane (PDMS) microfluidic device.  The differing geometric requirements 
of hydraulic valving (shallow, rounded) and biofilm growth (deep) were negotiated by 
creating a mold with two types of photoresist.  Fabrication incompatibilities between 
resist types were circumvented by protecting pre-existing photoresist structures with a 
solvent barrier layer using atomic layer deposition (ALD).  The final device successfully 
demonstrated the growth and subsequent segmentation of Escherichia coli biofilms, and 
was used to evaluate the effects of different concentrations of the detergent sodium 
dodecyl sulfate (SDS) on mature biofilms.   
4.1 Design 
4.1.1 Overview 
Macroscale biofilm studies have shown that biofilm formation is sensitive to a 
variety of growth parameters, and it is likely that no two biofilms can be compared [27, 
28].  To address biofilm variability, macroscale reactors such as the Modified Robbins 
Device or Calgary Biofilm Device often incorporate a method for performing assays on 
multiple sections of one biofilm [8, 11].  Performing different tests on separate portions 
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of one biofilm provides a significant advantage over parallel biofilm formation, as the 
variability between biofilms formed separately under the same conditions can preclude 
their accurate comparison when used as experimental and control groups in a biofilm 
assay.   
The compiled results of the previous chapters demonstrated that biofilms formed 
in the custom microfluidic reactor also exhibit variability between separate experiments.  
This was seen in the spread of optical density data in Chapter 2 – identical experiments 
performed on different days yielded biofilms with different optical densities, 
necessitating use of the percent difference between experimental and control groups as a 
metric.  Variability was also evident in comparing the control biofilms between 
experiments in the QSI studies in Chapter 3.  In one study, 96-hour Pseudomonas 
aeruginosa biofilms were 26 ± 11 µm thick, while another identical study yielded 
17 ± 2 µm-thick biofilms (Figure 3.4a and Figure 3.6d).  Considering the observed 
experiment-to-experiment variability, the macroscale approach of biofilm segmentation 
was adapted for integration in a microfluidic biofilm growth platform.   
The platform included one set of microfluidic channels where biofilms grew and 
were sectioned, placed on top of another layer of microfluidic channels that operated 
valves to manipulate the biofilms.  An overview of the device operation is depicted in 
Figure 4.1a, b.  The device was designed to have one central microfluidic channel where 
biofilms form and mature, with access to side channels blocked by closed valves (Figure 
4.1a).  After maturation, the central channel was divided into three sections using 
hydraulically actuated valves integrated in the PDMS structure.  Valves that formerly 
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blocked access to the side channels were opened, as shown in Figure 4.1b, to allow flow 
over each of the three sections of preformed biofilm.   
 
Figure 4.1. a) Schematic of device operation during biofilm growth, with side channels blocked by closed valves 
(solid black squares) b) Device operation during biofilm sectioning, with side channels open and central channel 
trisected by two closed valves c) Side-view schematic of open push-up valve integrated with two-depth channel 
d) Side-view schematic of closed push-up hydraulic valve with pressure applied to the liquid-filled control 
channel to close the valve. 
The valves to control flow and create the device configurations shown in Figure 
4.1a, b were integrated in two devices layers of PDMS using a hydraulically actuated 
“push-up” style valve [110] (Figure 4.1c).  Microchannels in the top layer contained 
biofilms and the surrounding media.  The bottom layer contained channels covered by a 
thin PDMS membrane and filled with liquid, to which pressure was applied for hydraulic 
actuation.  In the valve area, this pressure deformed the membrane and pressed it against 
the rounded ceiling of the top channel, thereby closing the valve (Figure 4.1d).  A three-




Figure 4.2.  Three-dimensional representation of the assembled platform in the biofilm growth configuration 
(corresponding to Figure 4.1a).  Pressure applied to Control Channel #2 closes the corresponding valve and 
prevents flow into the side channel.  The valve regulated by an unpressurized Control Channel #1 remains open, 
allowing biofilm growth in the central channel where there is flow.   
4.1.2 Design Consideration: Channel Depth and Shear Stress on Biofilms 
The amount of membrane deflection of a PDMS valve relies on a variety of 
factors, including the channel dimensions, the PDMS thickness, and the pressure applied 
[110].  The maximum deflection of a push-up-style valve is typically no more than 60 µm 
[110].  The channel geometry, including its depth, is directly related to shear stress; the 
shear stress in turn affects biofilm growth properties, such as thickness and structure [32, 
36, 116].  The relationship between channel geometry, flow rate, and shear stress in the 
microfluidic device can be expressed as 
  
   
 [      ] 
   
(4.1) 
where Q is the flow rate, µ is the fluid viscosity, W is the channel width, δ is the channel 
height, and L is the biofilm thickness at time t.  In the extreme case of no biofilm, the 
shear at the wall would be 
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(4.2) 
In order to more closely follow device parameters shown to create functional 
push-up valves in literature [110], the final device was designed with channel widths (W) 
of 350 µm.  Aiming to obtain biofilms that could be compared to the biofilms formed in 
the previous work presented in Chapters 2 and 3, the final device used a 100 µm-deep 
channel for biofilm growth.  Since the channel geometry has a large influence on the 
shear rate, as shown in Equation 4.2, the volumetric flow rate was adjusted in order to 
obtain the same shear rate as in the 500 µm-wide, first-generation microfluidic platform.  
The flow rate that was used, 7.5 µL/hr, combined with a 100 µm x 350 µm cross-
sectional area created an average flow velocity of 0.06 mm/s and a shear rate only 7% 
larger than that in the previous work.  
While a 100 µm channel depth was desired for biofilm growth, the integrated 
valves still required a channel less than 60 µm in depth.  Consequently, it was necessary 
to design a compromise between the valve and biofilm growth depth requirements.  The 
incorporation of these design constraints into the microfluidic platform is shown in 
Figure 4.1c, d.  In literature, the control channel is typically the top layer in the PDMS 
stack, and a PDMS membrane is spun on-top of the fluidic channel [108-110].  However, 
it is difficult to spin a uniform PDMS membrane on-top of a structure with large 
variations in topography, such as the multi-depth microfluidic mold required for the 
valved biofilm growth channel.  Since a uniform membrane can be obtained by spinning 
PDMS on top of a shallow, single-depth mold such as that for the control channel, the 
final device featured the control channel as the bottom-most layer.  The top layer of 
PDMS contained channels that were deep except in the locations to be sealed by valves.  
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In the valving areas, the channel profile was shallow and rounded, allowing for more 
complete sealing than a square profile.   
While literature indicates that a channel as deep as 60 µm can be sealed with a 
push-up valve, the shallow valving areas of the top layer of PDMS were designed to have 
a maximum depth (at the apex of the arc-shaped cross section) of approximately 35 µm.  
Designing a shallower channel than the hypothetical maximum provided a safety factor to 
ensure full sealing, with the additional possibility of lowering the required actuation 
pressure.  Minimizing the pressure required to deflect the membrane and seal the fluidic 
channel can also minimize the risk of rupturing the membrane and disabling the device.  
4.1.3 Design Considerations: Depletion of Oxygen and Nutrients Along Channel 
An important consideration for this device was maintaining biofilm uniformity 
along the channel.  While no clear dependence of biofilm growth on location within the 
channel was observed in previous work, it was considered possible that molecules 
essential for efficient biofilm growth may be depleted by the time fluid reached the 
biofilm closest to the channel outlet.  An assessment of the likelihood of depletion was 
performed considering both oxygen and available carbon sources for bacterial 
metabolism.   
Bacterial growth is highly dependent on the available carbon sources.  As Luria 
Bertani (LB) growth medium does not contain glucose, cultures grown in LB utilize 
amino acids as carbon sources [150].  In this work, growth media was introduced at a 
volumetric flow rate of 7.5 µL/hr, effectively refilling the channel with fresh growth 
media every 6 minutes.  As growth media was introduced faster than the ~20 minute 
doubling time of E. coli in LB, it was also assumed that the biofilm culture as a whole 
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was not restricted by carbon source availability.  While nutrient starvation was expected 
to exist within the biofilm structure, this may be attributed to diffusion, consumption, and 
degradation as a function of the biofilm itself and not of the reactor.   
In order to evaluate the potential for oxygen depletion within the microfluidic 
channel, a basic analysis of oxygen consumption and transport via convection and 
diffusion was performed.  The elements contributing to changes in oxygen concentration 
in the microfluidic biofilm growth reactor, as considered in this analysis, are outlined in 
Figure 4.3.   
 
Figure 4.3. Conceptual model of oxygen transport in microfluidic biofilm reactor.  This simplified model 
includes valve-less geometry and does not account for effects on changes in oxygen transport and reaction rates 
due to biofilm growth. 
Oxygen sources include dissolved gas in the growth media and environmental oxygen 
that diffuses through the PDMS and into the microfluidic channel.  Oxygen is consumed 
by the bacteria, dependent on their metabolic state; unconsumed oxygen exits the channel 
with waste.   
In the microfluidic biofilm growth reactor, oxygen is dissolved in the LB injected 
into the system.  A 1 L solution of LB typically contains 10 g tryptone, 5 g yeast extract, 
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and 10 g NaCl.  The salts and organic compounds in LB alter the solubility of oxygen in 
the water-based solution.  The change in the Bunsen coefficient can be derived from a 
modification of the Sechenov equation [151]: 
   
  
 
 ∑   
 
 
    
  ∑        
 
   
 
   
    
(4.3) 
Here, α is the Bunsen coefficient for the solute (oxygen) in LB and α0 is the Bunsen 
coefficient for oxygen in water at 35 °C.  Hi is a temperature-dependent parameter 
specific to the gas and the type of the i-th ionic species dissolved; zi and ci represent the 
charge and molar concentration of the i-th ionic species, respectively.  Similarly, Ki is a 
constant specific to the gas and the i-th organic compound dissolved in the solution, and 
corg,i is the molar concentration of the i-th organic compound.  Using the modified 
Sechenov equation, the oxygen concentration in LB at 35 °C was estimated to be 6.6 
mg/L or 0.206 mol/m
3
, based on  
  
 
      .  However, in practice, the composition of 
LB can vary between batches and experiments dependent on factors such as autoclave 
time and age of the solution [150].   
In addition to oxygen dissolved in the growth media, oxygen also can diffuse into 
the microfluidic channel through the PDMS, well known for its high gas permeability.  
The rate of oxygen diffusion into the channel is dependent on the difference in oxygen 
concentrations between atmospheric air and in the interior of the microfluidic channel.  
PDMS also has its own oxygen saturation limit, reported as 1.69 mol/m
3
 [152, 153].   
While experiments were not performed to obtain an oxygen consumption value 
specific to the bacteria and system used here, E. coli K-12 consumption of oxygen has 
been reported as approximately 4.31x10−20 mol/cell/s [154].  At the start of an 
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experiment, with a bacterial inoculum of OD600 0.25 (approximately 1.25x10
8
 cfu/mL), 
oxygen is consumed at a rate of 4.6x10−
12
 mmol/s.  As the bacteria within the biofilm 
divide, more oxygen will be consumed throughout the channel.   
A basic simulation was performed in COMSOL Multiphysics 4.1 to evaluate 
possible depletion given higher rates of oxygen consumption.  The model included 
dissolved oxygen in the growth media entering the system, oxygen from ambient air 
diffusing through the PDMS and into the media, and a flux of oxygen out of the channel 
floor representing bacterial metabolic activity.  The Laminar Flow physics mode was 
coupled to the Transport of Diluted Species physics mode in the subdomain representing 
the channel, and a separate Transport of Diluted Species physics mode was applied to the 
subdomain representing the PDMS.   
Diffusion of oxygen into the PDMS from ambient air was modeled using a stiff-
spring boundary condition [153], incorporating the partition coefficient into the term for 
oxygen flux at the air-PDMS boundary.  The diffusive flux of oxygen from air into the 
PDMS can be expressed as  
                           (4.4) 
where M is the stiff spring velocity, KP,air is the partition coefficient, Cair is the 
constant concentration of oxygen in ambient air, and cPDMS is the oxygen concentration 
on the PDMS side of the interface.  Oxygen diffusion from the PDMS into the media was 
modeled similarly to the PDMS-air boundary, with the diffusive flux of oxygen from the 
PDMS into the media expressed as  
                             (4.5) 
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where M is the stiff spring velocity, KP,PDMS is the partition coefficient, and cPDMS and 
cmedia are the oxygen concentrations on the PDMS and media sides of the interface, 
respectively.  Concentrations within the PDMS and the media were modeled using 
separate Transport of Diluted Species physics modes linked through the flux terms at the 
boundary between the PDMS and media.   
The consumption of oxygen by the biofilm was calculated assuming the bottom of 
the channel is completely covered with a monolayer of E. coli cells, each with an 





.  This value corresponds to the same number of cells contained in a 
suspension of OD600 10 filling the entire 0.84 µL channel volume.  The boundary flux of 
oxygen produced by biofilm metabolism can be expressed as  
                (4.6) 
where VO2 is the bacterial rate of oxygen consumption noted above.  While the 
consumption can be more accurately represented by Monod kinetics, allowing the rate to 
vary with oxygen concentration, the use of the maximum consumption rate was selected 
as representative of a condition most likely to induce oxygen depletion.  Additionally, 
while the biofilms formed within microfluidics are typically thicker than a monolayer of 
E. coli, they do not cover the entire channel floor.  Biofilms formed experimentally are 
also expected to have a lower average metabolic rate due to the inclusion of dead cells 
and extracellular matrix components within the biofilm structure.   
Flow within the microfluidic channel was modeled with the Laminar Flow 
physics mode, using the density and viscosity of water at 35 °C.  The boundary condition 
at the inlet was a normal inflow velocity of 0.06 mm/s, calculated using the channel 
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dimensions and volumetric flow rate of 7.5 µL/hr used in this work.  Within the 
Transport of Diluted Species physics mode, the boundary at the inlet was set to the 
calculated saturation concentration of oxygen in growth media, Cmedia.  
Relevant parameters for the simulation are summarized in Table 4.1; Figure 
4.44.4 shows the simulated media oxygen concentration near the channel inlet.   
Table 4.1. Parameters used for COMSOL simulation of oxygen transport. 
Parameter Value Source Description 
M 1x10
3










/s [152] Diffusion coefficient, oxygen in PDMS 
Cmedia 0.206 mol/m
3




 [153] Saturation concentration of oxygen in PDMS 
Cair 8.27 mol/m
3
 Calculation Concentration of oxygen in 35 °C air 
KP,air 8.20 Calculation Partition coefficient, air/PDMS 
KP,PDMS 4.89 Calculation Partition coefficient, PDMS/growth media 
VO2 4.31x10
−20





 Calculation Area density of cells on bottom of channel 
U0 6.0x10
-5
 m/s Calculation Normal inflow velocity with 7.5 µL/hr flow 
rate 
L 2.4 cm - Channel length 
w 350 µm - Channel width 
h 100 µm - Channel height 
Q 7.5 µL/hr - Volumetric flow rate  






Figure 4.4. Detail of oxygen concentration within growth media near the channel inlet from steady state 
COMSOL simulation of oxygen transport in the microfluidic system.  The simulation was based on the 
conceptual model of Figure 4.3 and used the parameters in Table 4.1.   
These results showed that the bacterial oxygen consumption rate is not large 
enough to fully deplete the media.  Close to the inlet, the primary source of oxygen for 
bacterial consumption is convection of oxygen dissolved in the growth media.  After an 
initial entry length, oxygen diffusion through the PDMS channel ceiling supplements 
oxygen convection [153].  The diffusive transport of oxygen allows the concentration 
along the bottom of the channel to approach a constant value of 0.2022 mol/m
3
, only 
1.8% less than the saturation concentration of oxygen in LB media.  Although oxygen in 
the media is consumed, it is at a low rate and has a minimal impact on the bulk oxygen 
concentration.   
While the above simulation provides general insight into the dynamics of 
microfluidic biofilm reactors, the biofilm growth rate and composition must be more 
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thoroughly accounted for, as in mathematical models presented in literature [32, 155], for 
a true representation of oxygen transport and reaction in the system.  For example, a 
biofilm whose biomass contains both live and dead bacteria will have a lower effective 
metabolic rate than a biofilm composed entirely of live bacteria.  Diffusion through the 
biofilm matrix itself must also be accounted for, as bacteria at different depths experience 
dissimilar oxygen and nutrient environments and accordingly exhibit different growth 
rates.  Growth of the biofilm also physically alters the system, effectively reducing the 
hydraulic diameter.  As this device was designed for end-point characterization of mature 
biofilms, the use of the above simplified model to verify sufficient oxygen throughout the 
channel is adequate for the purposes of this work.   
4.2 Fabrication 
4.2.1 Overview 
The channel profiles in both PDMS layers were created using photoresist molds 
patterned photolithographically on a silicon wafer.  Schematics of the device layout 
indicating the mask layers used are shown in Figure 4.5.  The fluidic channels were 
350 µm wide, and the central channel through which biofilms were grown was 24 mm 




Figure 4.5. Mask layout for PDMS molds.  Pink channels denote the top, biofilm-containing layer, and green 
channels denote the bottom, hydraulic control layer.  Valve locations are indicated by black squares at the 
intersections of the pink and green channels.  Drawn to scale.  
An overview of the entire fabrication process is given in Table 4.2; details of key 
fabrication parameters and intermediate steps are presented in the subsequent section.  
Briefly, to form a mold for the biofilm growth and valving layer, first a thin photoresist 
(AZ 9260) was patterned and rounded to form the shallow areas for valving.  While a 
negative-tone photoresist could be used in place of the AZ 9260, it cannot produce the 
rounded profile needed for valve sealing.  A thicker photoresist (Microchem KMPR 
1050) was patterned on top of the AZ 9260 to form the areas for biofilm growth.  This 
structure was then used as a mold to generate the inverse of this pattern in PDMS.  The 
mold for the other PDMS layer, providing control of the valves, was formed by a single 
layer of KMPR 1050.  The two PDMS layers were stacked on top of each other and 




Table 4.2. Process flow of the PDMS molding and assembly process. 
Step Cross-Sectional View 
1) Photolithography and rounding of thin positive 
photoresist (AZ 9260).  
 
2) Photolithography of thick, negative photoresist (KMPR 
1050) for biofilm growth areas.  
 
3) PDMS is poured onto the 2-depth fluidic mold.  
 
4) PDMS is peeled off the mold.  
 
5) In parallel, a separate mold for the control channel is 
fabricated from KMPR 1050.  
 
6) PDMS is spun onto the control channel mold and cured.  
 
7) Peeled 2-depth fluidic PDMS is aligned to and placed 
on top of the spun PDMS, creating a two layer PDMS 
stack on top of the control channel mold.  After curing the 
layers together, the PDMS stack can be peeled off and 
bonded to a glass substrate.   
 
 
4.2.2 Fluidic Mold Fabrication 
4.2.2.1 AZ 9260 Patterning and Hardbake 
The standard AZ 9260 patterning and rounding process involved spinning, 
developing, and exposing the resist to obtain the overall pattern, then baking it above its 
reflow temperature in order to form rounded structures.  In developing the fabrication 
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process, it was found that the first layer of photoresist patterned, AZ 9260, was very 
sensitive to subsequent patterning of the thicker layer of photoresist, KMPR 1050, on top 
of it.  The AZ 9260 typically dissolved during the KMPR 1050 development in SU-8 
developer.  A hardbake was implemented to counteract this to reduce solubility by 
exposing the photoresist to higher temperatures and longer periods of time than imposed 
by standard AZ 9260 rounding procedures (2 minutes at 120 °C, as described in [156, 
157]).  However, AZ 9260 would often crack during either the hardbake, one of the 
KMPR bakes, or the exposure to SU-8 developer.  While the general shape of the 
AZ 9260 would remain, the cracks rendered the pattern unusable as a PDMS mold.  Since 
PDMS is viscous before it is cured, it fills any cracks and sticks within the cracks during 
curing.  When the PDMS was peeled off the wafer, the cracked AZ 9260 was peeled off 
along with the PDMS, as shown in Figure 4.6.   
 
Figure 4.6. Photograph of PDMS molded with the 2-depth AZ 9260/KMPR mold.  Brown squares of cracked 
AZ 9260, indicated by the arrow, delaminated off the wafer and became stuck in the channels in the PDMS.  The 
AZ 9260 residues could not be removed from the PDMS without severely damaging the microfluidic channel.  
Initially, hardbake parameters were altered to investigate a potential solution to 
the cracking, as baking positive photoresist too quickly or at too high a temperature may 
produce temperature gradients that can crack the resist.  However, the resist must be 
baked to a sufficient degree to prevent dissolution in SU-8 developer.  Hardbake 





through iterative, chip-scale experiments.  Variables altered during this process include 
bake temperature, bake time, temperature ramping up or down from the bake, and the 
presence of a cover (inverted glass petri dish creating a chamber) over the chip.  Success 
of a hardbake was evaluated by immersing a patterned chip in SU-8 developer for 
5 minutes, with agitation.  Table 4.3 provides examples of the parameters altered and 
corresponding photographs of AZ 9260 test patterns throughout the process.    
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Table 4.3. Parameters varied in AZ 9260 hardbake characterization, including temperature, time, and whether 
the chip was covered during the bake.  Corresponding photographs were obtained after the hardbake and after 
immersing the chip in SU-8 developer for 5 minutes.  The red box highlights parameters used in further process 
development. 
Temperature (°C) Time (min) Covered After Hardbake After 5 min  
SU-8 Developer 
160 60 No 
 
(dissolved) 
160 60 Yes 
 
(dissolved) 
170 20 Yes 
  
175 10 Yes 
  
175 15 No 
 
(dissolved) 
175 15 Yes 
   





By evaluating the yield of intact test structures after full processing, the bake 
parameters that produce the most reliable results were identified.  The patterned wafer 
was placed on a room temperature hotplate, and the wafer was covered with an upside-
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down Pyrex® petri dish.  The wafer and petri dish were placed off-center on the hotplate 
surface so that a small section of the dish protruded from the edge of the hotplate, 
providing an opportunity for solvent evaporation.  The hotplate was then allowed to heat 
up to 175 °C for approximately 8 minutes, held at that temperature for 20 minutes, then 
allowed to cool naturally to room temperature, at which point the cover and wafer were 
removed.  However, even without cracks after the hardbake, subsequent exposure to SU-
8 developer still damaged the patterned AZ 9260, as in the last row of Table 4.3, with a 
yield of approximately 50%.  The introduction of a passivation layer improved yield by 
protecting the AZ9260 from SU-8 developer exposure, as discussed in the next section. 
The process parameters for the AZ 9260 processing and hardbake that were used 
in all of the following work are presented in Table 4.4.  
Table 4.4. Table of processing steps and parameters used for AZ 9260 lithography, rounding, and hardbaking. 
Step Parameters Description 
Spin HMDS 3000 rpm, 30 s Adhesion layer deposited immediately on 
dehydrated wafer 
Bake 150 °C, 3 min HMDS activation, solvent evaporation 
Spin 1
st
 AZ 9260 Layer 2000 RPM 
Ramp: 2 s 
Time: 60 s 
Spin dispense; creates film ~11 µm 
Bake Room temperature, 15 min 
60 °C, 5 min 




 AZ 9260 Layer 1500 RPM 
Ramp: 2 s 
Time: 60 s 
Spin dispense; Creates final film 
thickness ~ 24 µm 
Bake Room temperature, 15 min 
60 °C, 5 min 
100 °C, 20 min 
Evaporate solvent 
Rehydration >24 hours Rehydration time based on humidity 
Exposure 600 mJ/cm
2
 @ 365 nm Expose with Mask #3 (Appendix A) in 
intervals to avoid bubbles 
Develop 4:1 AZ400k, 10 min 
 
May rinse off residues with additional dip 
in fresh 4:1 AZ400k 
Hardbake 175 °C, 20 min 
Default hotplate ramp to bake 
temperature, natural cooldown.   
Solvent evaporation and profile rounding.  
Cover wafer with upside-down petri dish 
protruding from hotplate.  
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4.2.2.2 ALD Passivation of AZ 9260 
As an alternative to simply patterning the two photoresists one after the other, 
passivation of the first layer was investigated.  There are multiple methods used in 
literature for passivation of photoresist, including creating a crosslinked photoresist 
“skin” using UV ozone or chemical treatments [158, 159].  UV-ozone curing was 
attempted using a UVOCS ® T10X10 UV Ozone Cleaner and the parameters listed 
below in Table 4.5.  However, this treatment did not significantly decrease the amount of 
AZ 9260 degradation.   
Table 4.5. UV-ozone curing parameters and corresponding images of AZ 9260 structures after the hardbake 
(before UV-ozone exposure) and after testing stability by exposure to SU-8 developer.  UV-ozone exposure was 
performed in multiple steps to prevent overheating and bubbling of the resist; chips were exposed to 1 minute of 










In contrast to altering the photoresist itself to increase its chemical resistivity, 
others have used metal as a thin barrier layer in multiple process steps using the same 
photoresist [160].  Additionally, our group has demonstrated the passivation of a 
biosensor from biological media using atomic layer deposition (ALD) of aluminum oxide 
[113].  ALD materials deposition is suited for passivation of photoresist structures not 
only because it is thin and conformal, preserving the rounded shape of AZ 9260, but also 
allows for low temperature deposition, preventing thermal stresses on the resist.   
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ALD deposition of Al2O3 over patterned, rounded AZ 9260 test structures was 
deposited using a 150 °C process in a Beneq TFS 500 as in previous work [113].  The 
passivation ability of the ALD Al2O3 was characterized using two different layer 
thicknesses – 45 nm and 95 nm.  The quality of the passivation was evaluated by 
immersing chips with patterned AZ 9260 in SU-8 developer after passivation.  As shown 
in Table 4.6 below, 45 nm of Al2O3 still appeared to be insufficient to passivate against 
SU-8 developer; 95 nm of Al2O3 appeared to passivate the majority of the test chips 
adequately.   
Table 4.6. Chart depicting different squares on different test chips after deposition of the Al2O3 layer, and after 
immersing the chip in SU-8 developer for the time interval specified in the top row.  (a) Chips with 45 nm of 
Al2O3 passivation; (b) Chips with 95 nm of Al2O3 passivation. 
 ALD Al2O3 
Thickness 
After ALD  6 min SU-8 
Developer 
8 min SU-8 
Developer 












95 nm     
46/48 
 
    
 
When the Al2O3 failed, as in the 45 nm cases, the AZ 9260 structures completely 
dissolved, occasionally leaving residue on the wafer.  The two failed patterned structures 
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seen in the 95 nm Al2O3 samples still possessed intact patterns, albeit with cracks.  
However, since the 20 minute immersion period used is much longer than the actual 5-10 
minute development needed for 100 µm thick KMPR, a higher yield in fabricating the 
multi-depth mold was expected.  For the remainder of this work, patterned and hardbaked 
AZ 9260 was protected by an ALD Al2O3 passivation layer deposited at 150 °C with a 
target thickness of 95 nm. 
4.2.2.3 KMPR Patterning 
Using the parameters for the AZ 9260 lithography, hardbake, and passivation with 
ALD Al2O3 as presented above, the parameters for the KMPR 1050 processing were 
finalized.  Detailed procedures for this process are presented in Table 4.7.  
Table 4.7. Table of processing steps and parameters used for KMPR 1050 lithography on top of patterned and 
passivated AZ9260. 
Step Parameters Description 
Bake 150 °C, 5 min Dehydrate wafer surface  
Spin KMPR1050 500 RPM 
Ramp: 4 s 
Time: 10 s 
1000 RPM 
Ramp: 3 s 
Time: 30 s 
Creates film ~100 µm 
Pre-exposure Bake 95 °C, 25 min Evaporate solvent 
Expose 1000 mJ/cm
2
 @ 365 nm Expose with Mask #4 
(Appendix A) 
Post-exposure Bake 95 °C, 6 min Cross-links photoresist 
Develop SU-8 Developer, 6 min Isopropanol rinse after develop 
complete 
A summary of the entire fabrication process for the fluidic mold is presented in Figure 





Figure 4.7. Cross-sectional schematics and corresponding photographs of fluidic mold fabrication: a) patterning 
of AZ 9260 positive resist, b) resist rounding and hardbake, c) passivation with ALD Al2O3, and d) KMPR 1050 
patterning.  
4.2.3 Hydraulic Control Mold Fabrication 
The mold for the bottom layer of PDMS containing the valve control channels 
was fabricated from a single layer of Microchem KMPR 1050 patterned on a silicon 
wafer.  The thickness of the resist was not as critical as the thicknesses in the fluidic 
mold; the most critical feature was the PDMS membrane spun on top of the control mold, 
and given control of the PDMS thickness on top of the control mold, the thickness of the 
mold itself was less important.  A KMPR 1050 thickness of 40 µm produced membranes 
of appropriate thickness using the PDMS spin procedure described later in this chapter.  
The final process parameters for the KMPR 1050 processing for the hydraulic control 




Table 4.8. Table of processing steps and parameters used for KMPR 1050 lithography to create hydraulic 
control channels. 
Step Parameters Description 
Bake 200 °C, 10 min Dehydrate wafer surface  
Spin KMPR1050 500 RPM 
Ramp: 4 s 
Time: 10 s 
2000 RPM 
Ramp: 3 s 
Time: 30 s 
Creates film ~40 µm 
Pre-exposure Bake 95 °C, 20 min Evaporate solvent 
Expose 1000 mJ/cm
2
 @ 365 nm Expose with Mask #5 
(Appendix A) 
Post-exposure Bake 95 °C, 5 min Cross-links photoresist 
Develop SU-8 Developer, 5 min Isopropanol rinse after develop 
complete 
 
4.2.4 PDMS Layer Fabrication and Bonding 
Prior to pouring or spinning PDMS onto a mold wafer, the mold must be treated 
with a release agent to prevent PDMS adhesion to the features on the wafer, or breakage 
of the entire wafer while attempting to remove the PDMS.  The first release agent tried 
involved vapor phase deposition of a chlorosilane layer on the wafer surface by exposure 
to trimethylchlorosilane in a vacuum dessicator.  Upon exposure of the vapor to silicon 
dioxide on the wafer, silanol groups bond to the wafer surface.  The resulting coating is 
very stable and reduces the surface energy, allowing PDMS to be peeled from the mold 
during subsequent steps.  While this process has been performed previously within the 
MEMS Sensors and Actuators Laboratory at the University of Maryland [157], vapor 
phase silanization did not repeatably create an adequate release layer for this device, most 
often observed by permanent adhesion of PDMS to the Al2O3-passivated, multi-depth 
mold.  After accounting for variables such as silanization time and age of the 
trimethylchlorosilane solution, environmental factors were most likely responsible for the 
poor PDMS release.  Experimentation with release layers was performed during high 
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humidity weeks in the spring; however, silanization is very humidity sensitive, as silanes 
react readily with water.  While this may not be a critical factor for silicon silanization, 
Al2O3 silanization may be more sensitive and therefore did not succeed even when molds 
with silicon substrates were silanized in the same environmental conditions.  It is likely 
that molecular water on the Al2O3 surface reacts with the silane vapor before the hydroxyl 
groups on the Al2O3 surface react with the vapor.  Although standard silanization is an 
effective procedure for most PDMS molds, it was necessary to identify an alternative less 
sensitive to ambient humidity and more compatible with Al2O3.   
Detergent treatments have also been used as a surface treatment to promote 
PDMS release [161].  This process was adapted as a replacement for silanization to 
prevent  PDMS adhesion to patterned mold wafers in this work.  Both molds were treated 
with an aqueous solution of Alconox® powdered precision cleaner prior to PDMS 
processing to prevent PDMS adhesion to the mold surface.  Wafers were placed in a petri 
dish with 0.75% Alconox® detergent dissolved in deionized (DI) water for 2 minutes, 
removed, and allowed to air dry.   
PDMS for the control channel layer was mixed in a ratio of 20:1 (base : curing 
agent) and degassed in a vacuum dessicator.  The mixture was spun on top of the 
prepared control channel mold using a spin dispense, then spinning it at 1050 rpm for 
90 seconds.  The wafer was placed in a furnace programmed to ramp to 60 °C in 
5 minutes, then hold at 60 °C for 15 minutes.   
PMDS for the fluidic channel layer was mixed in a ratio of 5:1 (base : curing 
agent) and degassed.  The mixture was poured on top of the prepared fluidic channel 
mold, and the wafer placed in a furnace programmed to ramp to 60 °C in 5 minutes, then 
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hold at 60 °C for 15 minutes.  After curing, the PDMS was peeled off of the fluidic 
channel, and each chip was cut out of the wafer-sized PDMS piece using a knife.  A 
2 mm dermatological punch was used to punch holes at the inlets and outlets for fluidic 
tubing.   
After both PDMS layers were cured, each fluidic channel PDMS chip was aligned 
to and placed on top of the control channel mold with the spun PDMS cured on top.  A 
microscope was used to aid in alignment of each chip to the pattern on the control 
channel mold wafer.  The PDMS stack on top of the control channel mold wafer was 
placed in a furnace programmed to ramp to 80 °C in 10 minutes, then hold at 80 °C for 
3 hours.  The different base : curing agent ratios (20:1 in the control channel layer, 5:1 in 
the fluidic channel layer) create an excess of one of the components in each layer.  
Excess molecules are believed to interact with each other at the interface between the two 
layers, encouraging formation of a PDMS-PDMS bond [162].  After cooling the stack to 
room temperature, a knife was used to cut around the outline of each chip.  The entire 
PDMS stack for each chip was then carefully peeled off of the control channel mold.  A 
2 mm dermatological punch was used to punch holes at the inlets for the pressurized 
nitrogen used to control the valve actuation.   
After each of the PDMS chips on the wafer had been removed from the mold, 
they were permanently bonded to glass coverslips using oxygen plasma bonding.  Each 
PDMS chip and coverslip was placed in the chamber of a March Jupiter III O2 Plasma 
System with the surfaces to be bonded together oriented toward the plasma source.  In the 
final device fabrication process, surfaces were exposed to oxygen plasma for 30 seconds 
at 20 W and approximately 450 mTorr.  The coverslip was removed from the chamber 
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and the PDMS stack carefully placed on top.  Any bubbles were pressed out of the 
interface between the PDMS and glass as soon as possible after contact.  The plasma 
bond was strengthened by baking the devices in a furnace at 60 °C for 3 hours.  The 
entire PDMS layer fabrication and bonding procedure is detailed in Table 4.9.  
Table 4.9. Process flow of the final PDMS molding and assembly process. 
Step Cross-Sectional View 
1) PDMS is poured onto the 2-depth fluidic mold. 
 
2) After curing, PDMS is peeled off the mold. 
 
3) PDMS is spun onto a separate mold for the control 
channel, and cured. 
 
4) The peeled multi-depth fluidic PDMS is aligned to and 
placed on top of the spun PDMS. 
 
5) After curing the two layers together, the PDMS stack is 
peeled off of the control channel mold. 
 
6) The PDMS stack is permanently bonded to a glass 






Fluidic connections were made to the device as described in Chapter 2.  Holes 
were punched in the PDMS with a 0.2 mm dermatological punch.  Barbed tubing 
connectors (1/16”) were inserted into the resulting holes and connected with Tygon® 
tubing to either a syringe pump operating in infusion mode, or a microcentrifuge tube 
serving as a waste reservoir.   
4.3 Device Preparation and Testing 
4.3.1 Device Preparation 
When pressurized nitrogen was applied to an empty, non-liquid-filled control 
channel, the nitrogen gas diffused through the thin PDMS membrane at the valves and 
emerged in the fluidic channel as a bubble, interrupting flow and delaminating adherent 
biofilms.  Therefore, the first step in preparing the device for experimentation was 
conversion of the pneumatic channels into hydraulic channels by pre-filling them with DI 
water mixed with a drop of standard food coloring.  Tubing connected to the control 
channel inlets was coupled to a filled syringe dispensing dyed DI water at a flow rate of 
20 µL/hr.  Injection of the water forces gas in the control channel to diffuse through the 
membrane as it is replaced by the liquid.  As the control channels lack outlets, injection 
of dyed water was stopped when it was visually confirmed to have reached the ends of 
the channels.  The tubing connected to the control channels was subsequently connected 
to a tank of controlled, pressurized nitrogen.  To close the valves, a nitrogen pressure of 




4.3.2 Operation: Biofilm Growth 
Channels were sterilized using 70% ethanol at a flow rate of 20 µL/hr to introduce 
into the channels.  After rinsing the device with DI water at 20 µL/hr, the device was set 
to the biofilm growth configuration as in Figure 4.1a.  The E. coli strains used were BL21 
pGFP and K-12 MG1655.  The former was used for rapid characterization of biofilms 
formed, since it constitutively expresses green fluorescent protein (GFP) so staining was 
not required for fluorescence microscopy.  Wild type E. coli MG1655 was used as a 
model of wild type biofilm dynamics, and can only be imaged in conjunction with 
fluorescent stains.  All biofilms were initiated from cultures grown overnight at 250 rpm 
and 37 °C and diluted to an OD600 of 0.25 in LB media.  Suspensions were injected into 
the center channel of a sterilized device just until it was filled.  The suspension was 
incubated in the device under static conditions for 2 hours in a 37 °C incubator to allow 
bacterial adhesion to the PDMS channel floor.  With the device remaining in the 
incubator, flow of sterile LB growth media at 7.5 µL/hr was initiated after the incubation 
period and applied continuously for the set time period of biofilm growth. 
4.3.3 Operation: Biofilm Segmentation 
In the presented biofilm segmentation studies, biofilms were grown as previously 
described.  After the set period of biofilm growth time, the valve orientation was 
switched by releasing the pressure from the valves blocking the side channels, and 
applying pressure to the channels controlling the valves in the center channel.  Each 
section could then be exposed to treatment as shown in the schematic in Figure 4.1b; in 
this demonstration of the device’s applicability to biofilm studies, two sections were 
exposed to two different SDS concentrations (0.1% and 0.2% in LB media) at 7.5 µL/hr 
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for one hour, and one section was maintained as a control via exposure to LB media at 
7.5 µL/hr for one hour.   
4.3.4 Staining, Confocal Microscopy, Image Analysis 
Biofilms were stained, imaged, and analyzed based on the procedures developed 
in Chapters 2 and 3 [118, 119].  After biofilm formation or treatment, biofilms were 
rinsed with DI water then stained with the Filmtracer
TM
 LIVE/DEAD® Biofilm Viability 
Kit (Molecular Probes, Inc.), using equal proportions of SYTO9 and propidium iodide 
introduced into the biofilm-containing channels at a flow rate of 7.5 µL/hr.  The biofilms 
were rinsed again with DI water and imaged using confocal microscopy (Zeiss LSM 
710).  One location was imaged in each of the three segments per device; images were 
obtained close to the center point of each segment, approximately 4 mm away from the 
valve areas.  Confocal image stacks were quantitatively analyzed using COMSTAT [95], 
and visualized using Imaris (Bitplane, Inc.).  JMP® statistical analysis software was used 
for all statistical calculations.  
4.4 Results and Discussion 
4.4.1 Fabrication of Multiple Channel Profiles 
Deposition of a physical and chemical barrier via ALD proved a reliable method 
for patterning multiple resist formulations and profiles.  Using the methods described 
above, a 100% yield of intact AZ 9260 was obtained repeatably.  Successful patterning of 
the two photoresists to obtain the desired profiles is depicted by the profilometry data and 
scanning electron microscopy (SEM) image in Figure 4.8a-b.  A photograph of the 




Figure 4.8. a) Contact profilometry scan of mold at valve region, verifying the presence of the desired profiles.  
In the measured region, the rounded AZ 9260 section had a peak height of 36 µm, and the KMPR 1050 channels 
had a depth of approximately 97 µm.  b) SEM image of multi-depth structure created from two photoresists.  
Note the large difference in aspect ratios minimizes the appearance of curvature in the shallow section. c) 
Photograph of multi-depth mold.   
In order to create the device presented here, a new technique for protecting 
photoresist from chemical attack by solvents was developed.  This enabled multi-depth, 
multi-profile microfluidic channels.  While this demonstration of the technique only 
employed two types of resist, a multitude of photoresists or other polymeric materials 
with different patterning capabilities or thicknesses may be used to create varied 
microchannel geometries.  Using ALD passivation allows researchers the freedom to use 
any polymeric materials regardless of compatibility.  As the body of research on ALD 
processing expands, there are an increasing number of methods for low-temperature 
deposition of a variety of materials [163, 164], which in turn may be used for passivating 
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polymers more sensitive to high temperatures.  The ability to deposit very thin layers of 
high quality material facilitates the creation of even finer passivated photoresist patterns 
than those demonstrated here (on the order of 100 µm).  The fabrication technology of 
ALD passivation of photoresist to create multi-depth, multi-profile microfluidics also can 
be applied to an even broader number of applications outside the field of bacterial 
biofilms.  Microfluidics with mixed profiles can be applied to the growing number of 
tissue culture studies in microenvironments.  Microfluidic channels can be created to 
mimic in vivo spaces where tissue might form or be implanted [165].  Channels featuring 
deliberately patterned obstacles to flow could contribute an additional tool for 
understanding shear environments around in vivo perturbations such as atherosclerotic 
lesions [166].  Multi-depth microfluidics would also be useful in hydrodynamic studies 
where the channel dimensions would affect the results.  For example, the presence of a 
“ceiling” above an electrochemical sensor in a microfluidic channel has been shown to 
affect the sensor output [167]; this phenomenon could be further investigated by 
evaluating sensor performance in channels of different depths.  While this could be 
accomplished in a series of devices, each with its own unique channel depth, using one 
device with multiple channels and sensors not only eliminates device-to-device 
variability, but is more efficient and streamlined for the researcher.   
4.4.2 Valve Functionality 
The functionality of the valves was confirmed by introducing flow of DI water 
dyed with food coloring, then activating and releasing valves to control flow localization.  
Sample results of two device assessment tests are presented in Figure 4.9 and Figure 
4.10.  In one test, shown in Figure 4.9, one set of valves was actuated to create one 
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central channel, and green-colored water was injected into the device.  The valve 
configuration and the resulting flow pattern are shown in Figure 4.9b.  The valve 
orientation was then reversed, segmenting the channel into three sections.  Two sections 
were rinsed with undyed water (Figure 4.9c), then filled with different colors of water 





Figure 4.9. Photographs (left column) of the device taken at different stages over a several-hour testing period, 
and diagrams (right column) illustrating flow patterns and valve configurations, where solid black squares 
indicate closed valves. a) Filling the hydraulic control channels with red-dyed water, leaving the fluidic channels 
empty. b) Actuating one set of valves and creating flow through the center channel in the fluidic layer. c) 
Reversing valve orientation and rinsing out two of the three new channels with undyed DI water. d) Creating 
different flows in each of the three segmented channels.   
In a separate test (Figure 4.10), three different colors of water were used to 
simulate operation as a biofilm segmentation and testing device as postulated in Figure 
4.1a-b.  The use of dyed water also allowed for qualitative evaluation of leakage through 




Figure 4.10. Photographs of assembled devices with green water filling actuated control channels.  a) Device in 
biofilm growth orientation, with side channels blocked by closed valves.  Photograph corresponds to Figure 4.1a. 
b) Device in biofilm sectioning orientation, with side channels open and central channel sectioned by closed 
valves.  Photograph corresponds to Figure 4.1b.   
4.4.3 Biofilm Uniformity 
In order to use the device for biofilm studies with integrated controls, biofilms 
grown in the center channel must be uniform so that upon segmentation, the control 
section may be compared to the experimental sections in good faith knowing that prior to 
segmentation, all sections were comparable.  One concern was that the shallow valve 
areas might easily become clogged with biofilm, preventing further flow of growth media 
and biofilm growth beyond the clog.  However, this proved not to be the case, since 
biofilms preferentially did not grow in the valve area.  This is demonstrated by the 
images shown in Figure 4.11, where E. coli BL21 pGFP was grown in the center channel 
for 60 hours, and the control channels were filled with DI water and red food coloring, 




a) b)  
   
c) 
 
Figure 4.11. Surface reconstruction of confocal microscopy of 60-hour E. coli BL21 pGFP biofilm within the 
microfluidic channel.  Bacteria showed only green fluorescence; red areas are residual red food coloring 
absorbed into PDMS or the air-colored water interface in the control channel.  The red food coloring is visible 
due to its intrinsic low-level fluorescence.  a) Top view b) Angled view from side, c) Schematic representation of 
confocal images in the context of the layered PDMS channels.  Hydraulic control channel is depicted as 
completely filled with red-dyed water, whereas during confocal microscopy the water receded toward the open 
fluidic ports, leaving behind fluorescent residue.  
The lack of bacterial growth within the valve area was most likely due to the 
increased amount of shear stress in the narrow parts of the channel at the transition 
between the KMPR 1050 and AZ 9260 sections of the channel mold.  The shear stress in 
the center of the valve region, where the channel was deepest at approximately 35 µm, is 
about 8-fold greater than the shear stress in the 100 µm-deep biofilm growth areas.   
Increased shear imposed on the biofilm can reduce its thickness and can inhibit overall 
growth.   
Having verified that biofilms could be grown without clogging the shallow valve 
areas, uniformity was verified by growing E. coli MG1655 biofilms in the central channel 
100 µm 100 µm 
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for 48 hours, then staining, imaging, and analyzing the biofilm in each of the three 
segments.  The segments were denoted as I, II, and III corresponding to the segment 
closest to the inlet, the middle segment, and segment closest to the outlet as indicated in 
Figure 4.12a.  Two of the devices, Devices 1 and 2 as shown in Figure 4.12b, were tested 
in parallel, while Device 3 was tested one month later.  Results from the three devices 
tested are summarized in Figure 4.12b and samples of rendered confocal microscopy 
images from one device are shown in Figure 4.12c-e.   
 
Figure 4.12. a) Schematic of device operation during biofilm growth, with side channels blocked by closed 
valves.  Confocal microscopy images were obtained at the center of each of the three sections indicated (I, II, and 
III) b) Average biofilm thicknesses measured at imaged locations in the three devices tested.  Locations were 
positioned in the center of each section, with Section I closest to the inlet, and III closest to the outlet.  Dashed 
lines indicate averaged thickness across imaged locations for each device.  c-e) Surface rendered confocal 
microscopy images from Device 3, Sections c) I, d) II, and e) III.  Thicknesses were 17.0, 15.6, and 16.2 µm 
respectively. 
The results show that biofilms had small thickness variations within each device 
(SD < 2 µm, 13% of the average thickness at greatest).  Comparatively, this variation 
within a device was smaller than that between devices (SD = 3.9 µm, 23%).  Using an 
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unweighted analysis of variance (ANOVA), the variance between devices was 9.82 µm
2
 
(SE 2.25, P-value 0.8388), and the variance within a device between measurement 
locations was 0.61 µm
2
 (SE 0.67, P-value 0.0006).  The smaller differences in average 
thickness over one channel as compared between the three devices highlighted the 
importance of an integrated control.  These results confirmed that the biofilms were 
uniform throughout the center channel of each device, and had more uniform thicknesses 
than biofilms grown between devices. 
While biofilm variability in general can partially be addressed by performing an 
experiment multiple times and examining data trends, implementing internal controls 
adds an additional level of scientific rigor.  The need for these controls is clear in the 
device-to-device variation of biofilm thickness between devices in this work.  
Additionally, considering average thickness values obtained from devices prepared and 
tested at the same time varied similarly as devices tested on different dates, it is evident 
that between-device biofilm variation must be considered in experimental design.  In this 
demonstration of the valved biofilm sectioning device, within-device biofilm variation 
was less than between-device variation, as evident in the ANOVA results.  By comparing 
sections of one biofilm grown in one device, fewer iterations of an experiment would be 
required to obtain a representative understanding of the biofilm phenomena at play than if 
biofilms were grown in and compared between separate devices.   
4.4.4 Biofilm Segmentation 
The applicability of the device toward biofilm studies was demonstrated by 
testing biofilm sensitivity to SDS within a single device.  SDS is an anionic surfactant 
that has been shown to denature the bacterial cell wall by solubilizing its phospholipid 
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and protein contents [130, 168].  Exposure of bacterial biofilms to SDS has been used as 
a gauge of biofilm health [56], as well as a method for preventing biofilm formation 
[169].  After growing E. coli MG1655 biofilms for 60 hours, the valve orientation was 
switched, dividing the center channel into three sections, as depicted in Figure 4.1b and 
Figure 4.10b.  The three biofilm sections were either treated with 0.1% or 0.2% SDS, or 
remained untreated as a control.  Two devices were tested in parallel; the location of each 
treatment within the device (i.e. Section I, II, or III as pictured in Figure 4.13a) was 
varied between the devices as described in Table 4.10.  Results from the segmentation 
studies are summarized in Figure 4.13b, and samples of rendered confocal microscopy 
images from one of the devices are presented in Figure 4.13c-e.  In both devices, the 
control biofilm was thickest, and increasing the SDS concentration decreased the 
measured thickness in the applicable segment.  Additionally, there appeared to be no 
relationship between location of treatment administration and the results obtained; despite 
administration of treatments to biofilm segments at different locations within the device, 
both devices showed similar trends for thickness versus SDS concentration.  This 
observation relied on the observed biofilm uniformity within the channel (Figure 4.12), 
which enabled the assumption that the control segment represented the initial state of the 
biofilms in the other two segments before SDS exposure.  The results demonstrated the 





Table 4.10. Summary of treatments applied to biofilm sections in each device, describing how positioning of 
treatments was varied between the two devices tested.  Section I denotes the section closest to the inlet, and III 







Figure 4.13. a) Schematic of device operation during biofilm segmentation, with the central channel trisected by 
two closed valves.  Confocal microscopy images were obtained at the center of each of the three sections 
indicated (I, II, and III) b) Average biofilm thicknesses measured at the imaged locations in the two tested 
devices with different SDS exposure levels.  c-e) Surface rendered confocal microscopy images of E. coli biofilms 
in Device 1 with c) no treatment (control) d) exposure to 0.1% SDS, and e) exposure to 0.2% SDS.  Biofilm 
thicknesses were 24.9, 7.9, and 0.3 µm respectively. 
The device presented here is suited for inverted confocal microscopy imaging, as 
the light path must only pass through the coverslip and the bottom-most PDMS layer 
before encountering the biofilm.  While using confocal microscopy is a standard method 
for biofilm observation and quantification [170], more information about biofilms can be 
gathered in a continuous manner by integrating sensors into the microfluidic platform.  
As the biofilm grows on top of PDMS, integration of electrical or mechanical sensors 
Section 
Treatment 
Device 1 Device 2 
I Control 0.1% SDS 
II 0.1% SDS 0.2% SDS 
III 0.2% SDS Control 
132 
 
would require sensor fabrication within or on top of the PDMS [171, 172], or integration 
of pre-fabricated sensors into the PDMS [173, 174].  While possible, these processes may 
require extensive characterization so that the sensor integration fabrication processes do 
not preclude valve operation.  The device is immediately compatible with off-chip, 
continuous optical detection methods such as optical density [118, 133] or on-chip 
fluorescence [175].  The integrated valves featured in this work allow the entire device to 
remain compact and to be integrated without opaque instrumentation impeding 
lightpaths.   
Advancement of this methodology to include integrated biofilm optical density 
measurement for continuously evaluating the biofilm state, as developed and applied in 
Chapters 2 and 3, will provide additional information unattainable with end-point 
measurements from microscopy [118, 133].  For instance, any instantaneous changes in 
the biofilm structure can be measured as the valve orientations are switched for biofilm 
sectioning.  Real-time biofilm sensitivity to antibiotics or other anti-biofilm treatments 
can also be measured, offering more detailed information about antibiotic tolerance 
kinetics than end-point microscopy can provide.  Additionally, the development of 
biofilm non-uniformity or maintenance of uniformity throughout the channel can be 
monitored, providing a metric to compare to analytical bacterial biofilm growth models.   
Expansion of the device design to include more biofilm sections than the three 
demonstrated in this work will also allow more experiments to be performed in the same 
platform.  These experiments could range from the identification of appropriate staining 
procedures to the evaluation of biofilm sensitivity to antibiotics or shear stress.  In 
addition to the variety of experiments that can be performed on a mature biofilm, there 
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are also a number of growth factors that can be altered to produce varied biofilm 
morphologies; these growth variables include growth media, flow conditions, bacterial 
strain, and the degree of maturity [32, 176, 177].  In extending the variety of biofilms 
grown in the platform, biofilm uniformity must be characterized for each introduction of 
a new growth variable in the system to ensure that each section of the biofilm is initially 
comparable to the others. 
4.5 Chapter Summary 
Microfluidics provide a convenient platform for targeting the challenge of 
bacterial biofilms, enabling scientific studies and drug testing in a small format easily 
integrated with many sensing modalities.  The issue of biofilm variability between 
microfluidic devices was addressed by creating a platform where one biofilm was grown 
and sectioned into discrete segments that were subjected to different treatments in parallel 
or used as internal controls.  Sectioning was achieved using hydraulically actuated valves 
integrated with a two-depth biofilm growth channel, enabled by ALD passivation of a 
photoresist mold to bypass incompatibilities between multiple photoresists.  The platform 
was successfully used to segment biofilms and evaluate sensitivity to SDS.  Through this 
work, the need for integrated controls observed in previous biofilm studies was 
confirmed, and the presented platform was proven to address this need.  The novel ALD 
passivation technology developed to enable this work has an even broader impact beyond 
the biofilm research community, as photoresist passivation enables a host of microfluidic 
devices with varied cross-sectional geometries.  This work introduces an additional 
degree of freedom in channel geometry into the microfluidic toolbox, thereby expanding 
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experimental design options as well as the broader base of scientific knowledge produced 





5.1 Summary  
A set of new microfluidic technologies were designed specifically to aid 
investigations of bacterial biofilms.  Many types of bacterial biofilm growth platforms 
and evaluation methods exist and are widely employed at both the macroscale and 
microscale, and each presents a set of advantages and disadvantages for biofilm studies.  
The platforms created in this work were inspired by and combine the benefits of separate 
technologies to address challenges in the current technology.  The non-invasive, 
continuous optical density measurements used in macroscale reactors with large sample 
volumes was integrated with the highly parallel studies and controllable 
microenvironments unique to microfluidic systems.  The biofilm variability typically 
observed between microfluidic devices was addressed by using integrated valves to 
emulate techniques employed in larger reactors, where a single biofilm is partitioned into 
separate, comparable segments that can each be assayed as representatives of the original 
biofilm.   
The first platform developed in this work addressed the requirements for 
continuous, non-invasive, and label-free evaluation of bacterial biofilms formed in 
microfluidics, as well as the need for efficient, multiplexed formation of biofilms 
assessed with traditional biofilm measurement techniques.  This was accomplished by 
integrating optical density monitoring of biofilms with a microfluidic flow reactor for 
biofilm formation.  Commercial, off-the-shelf photodiodes and LEDs served as optical 
detectors and light sources.  These measurement components were aligned to a 
microfluidic channel, in which biofilms were grown and continuously measured by 
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monitoring the decrease in light transmitted through the growing biofilm.  The optical 
response over biofilm growth was compared to results obtained using confocal 
microscopy.  The correlation between optical density and biofilm thickness confirmed the 
validity of this measurement technique as applied to biofilms in microfluidics.  As 
confocal microscopy typically interferes with the biofilm phenotype by requiring a 
fluorescent label, the use of optical density as a comparable measurement method 
provides a more accurate representation of the biofilm state.   
The microfluidic platform for optical density measurement of biofilms was used 
in a scientific investigation of the dependence of bacterial biofilm growth on quorum 
sensing.  First, biofilms formed by Escherichia coli with varying degrees of quorum 
sensing activity were evaluated.  The method confirmed that a mutant strain of E. coli 
incapable of AI-2 synthesis formed thinner biofilms than wild type E. coli, and adding 
extracellular AI-2 to the mutant biofilm was able to partially restore thickness.  Having 
proved the ability of the platform to distinguish between biofilms of different thicknesses 
formed in the microfluidic channel, the platform and measurement technique were 
applied toward assessing the potential for biofilm inhibition by AI-2 analogs.  While a 
number of AI-2 analogs have been verified as quorum sensing inhibitors, their potential 
for inhibiting biofilm formation had not been previously investigated.  The microscale 
biofilm reactor minimized the amount of analog required for experiments, allowing 
efficient use of the small samples generated in early research of new treatments.  The 
results were the first demonstration that AI-2 analogs not only can inhibit bacterial 
biofilm formation, but when applied in conjunction with a traditional antibiotic, can 
virtually eliminate mature biofilms.   
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The second platform developed in this work was designed to provide improved 
experimental control by addressing variability observed between biofilms in different 
experiments.  Hydraulically actuated PDMS valves were integrated with microfluidic 
channels to divide a biofilm into separate segments for further experimentation.  In the 
development of this platform, a novel fabrication technique was developed for creating 
multi-depth microfluidic channels required for valve integration with biofilm growth 
channels.  The incompatibilities between the different photoresists used to create the 
multiple depths were bypassed by using ALD to passivate layers with Al2O3 deposited at 
a low temperature compatible with the photoresist.  The ability of the fabricated 
platforms to host uniform biofilms was confirmed, establishing the validity of using 
sections as representatives of the entire biofilm.  Biofilms were partitioned with the 
integrated valves, and the resulting segments were used in experiments assessing 
bacterial biofilm sensitivity to SDS.  The use of comparable segments of one biofilm 
contributed to the validity of the results, as observed differences could be attributed to 
SDS treatment as opposed to naturally occurring variation within one biofilm, between 
devices, or between devices tested on different days.   
5.2 Future Work 
The work presented in this dissertation reveals many avenues for further 
investigation.  These research directions can be classified as either technology-driven, 
improving the functionality and applicability of the developed microfluidic platforms, or 
as application-driven, advancing the development of new anti-biofilm treatments.   
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In this work, biofilms formed within the valved device for biofilm segmentation 
were evaluated with confocal microscopy.  A continuous biofilm measurement method – 
optical density monitoring – was developed for use with microfluidic platforms, and an 
immediate technological advancement of the valved device would be its integration with 
CCD-based optical density measurement.  Detailed spatiotemporal information obtained 
during biofilm formation in the valved device would not only reveal dynamics of applied 
treatments, but could also be used to further investigate and characterize biofilm 
uniformity in the microfluidic channel.    
The device for biofilm segmentation developed here was designed to divide 
biofilms into three sections.  The throughput of biofilm studies could be expanded if the 
channel could be divided into more sections.  However, before redesigning the geometry 
of the device presented in this work, additional characterization is required to evaluate the 
interactions between the biofilm and channel geometry.  In this work, biofilms were 
deemed uniform based on measurements obtained in the center of each section, 4 mm 
away from either a valve or a fluidic inlet or outlet.  It is likely that the morphology of the 
biofilm changes with the altered flow closer to channel features such as valves or fluidic 
inlets and outlets, and may be different from the biofilm in the center of the section.  
Future work with this device should determine the limit on how close together valves can 
be positioned while allowing development of a uniform biofilm unaffected by 
perturbations in flow.  Integration of CCDs for continuous optical density measurement 
could provide this data and inform the rearrangement of valves and channels for 
increasing the number of sections to increase the throughput of biofilm experiments.   
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When characterizing new antibacterial treatments, it is common to evaluate the 
minimum drug concentration necessary to completely eliminate the bacterial population.  
In order to streamline biofilm research using system automation, a diffusive gradient 
mixer can be added upstream of the existing platform, analogous to the device developed 
by Kim et al. [111].  The configuration use valves to prevent flow through the side 
channels and through the gradient mixer during growth.  For experimentation, one set of 
valves would close in order to divide the biofilm growth channel into sections, while 
another set would open to allow flow through the side channels and the gradient mixer.  
This configuration would deliver different concentrations of the same drug to different 
sections of the biofilm, as depicted in Figure 5.1.   
 
Figure 5.1. Schematics of valved device for biofilm segmentation integrated with a diffusive gradient mixer for 
generating multiple concentrations of a solution, e.g. antibiotic or AI-2 analog, on-chip.  a) Device configuration 
during biofilm growth, with side channels and gradient mixer blocked by closed valves (solid black squares) b) 
Device operation during biofilm sectioning and exposure of biofilm sections to different concentrations of drugs, 
with side channels open and central channel trisected by two closed valves. 
The integration of concentration gradients generated on-chip could be used to evaluate 
the minimum antibiotic concentration needed to induce synergistic biofilm inhibition 
with an AI-2 analog.  Conversely, a complex mixer with three inlets, for growth media, 
antibiotic, and AI-2 analog could be constructed in order to vary the antibiotic and AI-2 
analog concentrations simultaneously and determine the combination most effective for 
biofilm inhibition.   
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As previously mentioned, the technologies developed here can be employed as 
pharmaceutical testbeds.  The types of biofilms grown in the device can be expanded 
from monocultures to co-cultures of multiple species, more similar to the diverse 
ecosystems found in biofilm infections.  Co-cultures would be particularly useful in 
testing the AI-2 analogs used in this work, as the analogs can be tailored to inhibit 
quorum sensing in several species at once, or to target one type of bacteria within a co-
culture [84].  This concept could be expanded to modeling infections formed on tissue by 
forming a biofilm on a monolayer of epithelial cells, similar to the work of Kim et al. 
[124].  Such an infection model could be used first to characterize how biofilms interact 
with the epithelial cells, then expanded to evaluate possible changes in the biofilm 
response to treatment in the presence of the simulated tissue.  Additionally, while 
treatments may be effective at eradicating biofilms, they may produce toxicity in the host.  
Use of an on-chip infection model would aid in evaluating potential side effects.  While 
replication of in vivo conditions in a microfluidic device is unlikely, preliminary studies 
performed in a microfluidic device can serve as a guide for designing studies in animal 
models of infection.   
5.3 Conclusion  
The global health challenge presented by the tenacity of bacterial biofilm 
infections has created a need for efficient in vitro tools and methods for accurately 
evaluating biofilms and their response to new treatments.  This need was addressed in 
this dissertation through the development of microfluidic platforms for in-line evaluation 
of biofilm state as well as for controlled, high-throughput performance of assays on 
biofilms.  The results generated show the promise of using microfluidics for biofilm 
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studies, especially as applied to drug development.  These microfluidic platforms will 
serve as a foundation for developing in vitro biofilm models that may be used in the 




Appendix A: Masks Used 
Mask #1  














Pattern to form mold for valve areas of fluidic channel in the multi-depth 






Pattern to form mold for deep areas in fluidic channel in the multi-depth 






Pattern for control channel mold used to actuate valves in the multi-depth 





Appendix B: Circuit Diagrams 
 
Photodiode Measurement  
The circuit diagram for measuring the outputs of four photodiodes (corresponding 
to two microfluidic channels with two measurement windows each) using two 






The circuit diagram for measuring the outputs of four photodiodes (corresponding 
to two microfluidic channels with two measurement windows each) using two 
analog input ports on the USB-6221 DAQ card is shown below.  Not shown is the 
8 V DC power supply connected to the 5 V voltage regulator (BA17085) 





Appendix C: Matlab Code 
Basic OD Measurement 
This program reads a series of files output by LabVIEW, each of which contains 
readings from photodiodes and from the multiplexer, along with a time stamp and the 
digital counter value (determining the multiplexer state).  The program separates the 
multiplexer signal into signals from individual photodiodes, and converts these values 












%read in CSV file 
filename = input('Enter the filename of the baseline file: ', 
's'); 
















    if indicator(i)==0 
        V1(j1)=V_combined(i); 
        t1(j1)=time_s(i); 
        j1=j1+1; 
    elseif indicator(i)==1 
        V2(j2)=V_combined(i); 
        t2(j2)=time_s(i); 
        j2=j2+1; 
    elseif indicator(i)==2 
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        V3(j3)=V_combined(i); 
        t3(j3)=time_s(i); 
        j3=j3+1; 
    elseif indicator(i)==3 
        V4(j4)=V_combined(i); 
        t4(j4)=time_s(i); 
        j4=j4+1; 








%Take voltage from data and convert to current, then to 
illuminance (I) 















































% Average the OD values obtained by photodiode pairs.  These 











This program smooths data in order to eliminate transient fluctuations in 
photodiode signals.  This is accomplished by dividing the data into sections, each of 
which is fitted to a quadratic function.  The program below has been shortened for fitting 
one data set (whereas it was used mostly for simultaneously smoothing multiple data sets, 








x_w=time_wt; % Time 
y_w=abs_wt; % Optical density 
  
length = length(x_w); 
  
% Use least-squares fit technique 
% Split up the data into overlapping chunks; each chunk will be 
1000 units long, overlap by 500.  Values in the overlap will be 
averaged 
  








    j; 
    i=i+1; 
    % Get a chunk of data 
    y1=y_w(j:j+increment); 
    x1=x_w(j:j+increment); 
     
     
     
    % Get the fit for the chunk 
    pcoeff_1=polyfit(x1, y1, 2); 
    x_est_1=x2; 
    y_est_1=polyval(pcoeff_1,x_est_1); 
     
    % IF i>1, take the first (increment/2) values and average 
them with the last (increment/2) values in the main compilation vector.   
    % Then, set the first (increment/2) values of the current 
chunk to this average.  Later, this chunk will be added not at the end 
of the main compilation vector, but (increment/2) values before the 
start point of the chunk (j-increment/2). 
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    if i>1 
        lc=size(y_est_w); 
        lc=lc(1); 
        lc_start=lc-increment/2+1; 
        
y1_avg=0.5.*((y_est_1(1:increment/2))+y_est_w(lc_start:lc)); 
        y_est_1(1:increment/2)=y1_avg; 
         
    y_est_w=[y_est_w(1:lc_start);y_est_1]; 
    x_est_w=[x_est_w(1:lc_start);x_est_1]; 
     
    else  
    y_est_w=[y_est_w;y_est_1]; 
    x_est_w=[x_est_w;x_est_1]; 
    end 
     
    % Now put the fit increment/2 from the end of the main 
compilation vector.  Do this by letting compilation vector be 
y_est_w(1:lc_start), then tack on y_est_1 etc.  
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